合成路线1
该中间体在本合成路线中的序号:
(I) The reaction of ethanolimine (I) with m-methoxyphenylacetone (II) gives the corresponding Schiff base (III), which is reduced with H2 over Pd/C to the corresponding secondary amine (IV). Methylation of (IV) with HCHO-HCOOH yields 1-(m-methoxyphenyl)-2-(N-(2-hydroxyethyl)-N-methylaminoipropane (V), which is treated with SOCl2 to afford the 2-chloroethyl derivative (VI). Finally, this compound is condensed with benzhydrol (VII) by means of NaNH2 in refluxing benzene, and treated with HCl.
【1】
Lindner, E.; Ehrhart, G.; Ott, H. (Aventis Pharma AG); m-Methoxy-alpha-methyl-phenethyl-amino-diphenylmethyl ethers. US 3565955 .
|
【2】
Mannhold, R.; HOE-263. Drugs Fut 1985, 10, 6, 458.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
29663 |
1-(3-methoxyphenyl)acetone
|
3027-13-2 |
C10H12O2 |
详情 | 详情
|
(III) |
29664 |
2-[[(E)-2-(3-methoxyphenyl)-1-methylethylidene]amino]-1-ethanol
|
|
C12H17NO2 |
详情 |
详情
|
(IV) |
29665 |
2-[[2-(3-methoxyphenyl)-1-methylethyl]amino]-1-ethanol
|
|
C12H19NO2 |
详情 |
详情
|
(V) |
29666 |
2-[[2-(3-methoxyphenyl)-1-methylethyl](methyl)amino]-1-ethanol
|
|
C13H21NO2 |
详情 |
详情
|
(VI) |
29667 |
N-(2-chloroethyl)-N-[2-(3-methoxyphenyl)-1-methylethyl]-N-methylamine; N-(2-chloroethyl)-1-(3-methoxyphenyl)-N-methyl-2-propanamine
|
|
C13H20ClNO |
详情 |
详情
|
(VII) |
11845 |
Diphenylmethanol; Benzhydrol
|
91-01-0 |
C13H12O |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(B) The synthesis of GYKI-13504 is as follows:
Trifluoroacetophenone (I) is reacted with triphenylbenzyl phosphonium chloride (II) in the presence of sodium methylate and this reaction yields stilbene (III). Stilbene (III) is then hydrogenized in the presence of charcoal palladium catalyzer and the yielded propane derivative (IV) is brominated with 1,2-dibromoethane. The brominated compound (V) is reacted with anizole (A) according to the Friedel Crafts' reaction. The yield (VI) is treated with pyridine hydrochloride and the phenol derivative (VII) is reacted with 2-chloroethanol tosylate (VIII) in the presence of potassium hydroxide. The chloroethoxy (IX) is treated with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and the (E)-isomer (X) is obtained with fractionated crystallization. This latter product is reacted with 2-aminoethanol (B) to obtain the end product GYKI-13504.
【1】
Abraham, G.; Horváth, T.; Toldy, L.; Borvendeg, J.; Csányl, E.; Kiss, E.; Szente, I.; Tory, K. (Egis Pharmaceuticals Ltd.); 1,1,2-Triphenylpropane and -propene derivatives. AT 368989; BE 0884716; DD 152536; ES 494286; GB 2058061; GR 69821; HU 18253 . |
【2】
Borvendeg, J.; GYKI-13504. Drugs Fut 1985, 10, 5, 395.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(A) |
23767 |
Methoxybenzene; Methyl phenyl ether; Anisole
|
100-66-3 |
C7H8O |
详情 | 详情
|
(I) |
29349 |
2,2,2-trifluoro-1-phenyl-1-ethanone; 4-Chloro-2-fluorotrifluoroacetophenone
|
434-45-7 |
C8H5F3O |
详情 | 详情
|
(II) |
42794 |
Benzyl(triphenyl)phosphonium chloride
|
1449-46-3 |
C25H22ClP |
详情 | 详情
|
(III) |
29351 |
1-[(Z)-3,3,3-trifluoro-2-phenyl-1-propenyl]benzene
|
|
C15H11F3 |
详情 |
详情
|
(IV) |
29352 |
1-(3,3,3-trifluoro-2-phenylpropyl)benzene
|
|
C15H13F3 |
详情 |
详情
|
(V) |
29353 |
1-(1-bromo-3,3,3-trifluoro-2-phenylpropyl)benzene
|
|
C15H12BrF3 |
详情 |
详情
|
(VI) |
29354 |
1-methoxy-4-(3,3,3-trifluoro-1,2-diphenylpropyl)benzene
|
|
C22H19F3O |
详情 |
详情
|
(VII) |
29355 |
4-(3,3,3-trifluoro-1,2-diphenylpropyl)phenol
|
|
C21H17F3O |
详情 |
详情
|
(VIII) |
14632 |
2-chloroethyl 4-methylbenzenesulfonate; 2-Chloroethyl-p-toluenesulfonate
|
80-41-1 |
C9H11ClO3S |
详情 | 详情
|
(IX) |
29356 |
1-(2-chloroethoxy)-4-(3,3,3-trifluoro-1,2-diphenylpropyl)benzene
|
|
C23H20ClF3O |
详情 |
详情
|
(X) |
29357 |
1-(2-chloroethoxy)-4-[(E)-3,3,3-trifluoro-1,2-diphenyl-1-propenyl]benzene
|
|
C23H18ClF3O |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(B) Elimoclavine (I) obtained by fermentation is first O-mesylated and then the mesyl group in the product (II) displaced by 2-aminoethanol to give the hydroxyethylamino derivative (III). Repeated acylation of (III) with mesyl chloride affords the N,O-dimesylate (IV), which exchanges the O-mesyl group for an azido group on treatment with sodium azide to give the base (VI). Salt formation with maleic acid gives RGH-7825 (1,2).
【1】
Mago, N.K.E.; et al. (Gedeon Richter Ltd.); Novel ergol-8-ene and ergolin compounds and process for preparing same. DE 3026271; HU 180467 .
|
【2】
Nogradi, M.; RGH-7825. Drugs Fut 1985, 10, 9, 753.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(A) |
27347 |
N,N-dicyclohexylamine
|
101-83-7 |
C12H23N |
详情 | 详情
|
(I) |
27346 |
[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methanol
|
|
C16H18N2O |
详情 |
详情
|
(II) |
27348 |
[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl methanesulfonate
|
|
C17H20N2O3S |
详情 |
详情
|
(III) |
27349 |
2-([[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]amino)-1-ethanol
|
|
C18H23N3O |
详情 |
详情
|
(IV) |
27350 |
2-[[[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl](methylsulfonyl)amino]ethyl methanesulfonate
|
|
C20H27N3O5S2 |
详情 |
详情
|
(V) |
27351 |
N-[[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]-N-(2-azidoethyl)methanesulfonamide
|
|
C19H24N6O2S |
详情 |
详情
|
(VI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(XI) The condensation of dimethylacetone-1,3-dicarboxylate (X) with ethanolamine (XI) yields methyl 3-(methoxycarbonylmethyl)-3-(2-hydroxyethylamino)acrylate (XII), which is cyclized with bromoacetaldehyde diethylacetal (XIII) affording methyl 1-(2-hydroxyethyl)-3-methoxycarbonylpyrrol-2-acetate (XIV). Acylation of (XIV) with methanesulfonyl chloride (XV) and triethylamine in CH2Cl2 yields the corresponding mesylate (XVI), which by treatment with methyl iodide in refluxing acetonitrile is converted into methyl 1-(2-iodoethyl)-3-methoxycarbonylpyrrole-2-acetate (XVII). The cyclization of (XVII) with NaH in DMF yields dimethyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylate (XVIII), which is hydrolyzed with KOH in refluxing methanol - water to the corresponding diacid (XIX). Partial esterification of (XIX) with isopropanol and HCl gives isopropyl 1,2-dihydro-3H-7-carboxypyrrolo[1,2-a]pyrrole-1-carboxylate (XX), which is decarboxylated by heating at 270 C affording isopropyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylate (XXI). Benzoylation of (XXI) with N,N-dimethylbenzamide (XXII) and POCl3 in refluxing CH2Cl2 yields isopropyl 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylate (XXIII), which is finally hydrolyzed with K2CO3 or NaOH in methanol - water.
【1】
Blancafort, P.; Serradell, M.N.; Hillier, K.; Castaner, J.; BPPC. Drugs Fut 1981, 6, 11, 669.
|
【2】
Muchowski, J.M.; Kluge, A.F. (Roche Bioscience); 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids derivatives and process for the production thereof. DE 2731678; ES 460706; ES 470214; FR 2358406; FR 2375234; GB 1554075 .
|
【3】
Arrigoni-Martelli, E.; Castaner, J.; Blancafort, P.; Serradell, M.N.; RS-37,619. Drugs Fut 1983, 8, 10, 871.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
22692 |
dimethyl 3-oxopentanedioate
|
1830-54-2 |
C7H10O5 |
详情 | 详情
|
(XI) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XII) |
30764 |
dimethyl (E)-3-[(2-hydroxyethyl)amino]-2-pentenedioate
|
|
C9H15NO5 |
详情 |
详情
|
(XIII) |
12113 |
2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal
|
2032-35-1 |
C6H13BrO2 |
详情 | 详情
|
(XIV) |
30765 |
methyl 1-(2-hydroxyethyl)-2-(2-methoxy-2-oxoethyl)-1H-pyrrole-3-carboxylate
|
|
C11H15NO5 |
详情 |
详情
|
(XVI) |
30766 |
methyl 2-(2-methoxy-2-oxoethyl)-1-(2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]ethyl)-1H-pyrrole-3-carboxylate
|
|
C14H21NO5S |
详情 |
详情
|
(XVII) |
30767 |
methyl 1-(2-iodoethyl)-2-(2-methoxy-2-oxoethyl)-1H-pyrrole-3-carboxylate
|
|
C11H14INO4 |
详情 |
详情
|
(XVIII) |
30768 |
dimethyl 2,3-dihydro-1H-pyrrolizine-1,7-dicarboxylate
|
|
C11H13NO4 |
详情 |
详情
|
(XIX) |
30769 |
2,3-dihydro-1H-pyrrolizine-1,7-dicarboxylic acid
|
|
C9H9NO4 |
详情 |
详情
|
(XX) |
30770 |
1-(isopropoxycarbonyl)-2,3-dihydro-1H-pyrrolizine-7-carboxylic acid
|
|
C12H15NO4 |
详情 |
详情
|
(XXI) |
30771 |
isopropyl 2,3-dihydro-1H-pyrrolizine-1-carboxylate
|
|
C11H15NO2 |
详情 |
详情
|
(XXII) |
30757 |
N,N-dimethylbenzamide
|
611-74-5 |
C9H11NO |
详情 | 详情
|
(XXIII) |
30772 |
isopropyl 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
|
|
C18H19NO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) The condensation of 2-nitroimidazole (I) with methyl chloroacetate (II) by means of sodium methoxide in hot DMF gives methyl (2-nitro-1-imidazolyl)acetate (III), which is then treated with ethanolamine (IV) in methanol.
【1】
Castaner, J.; Robinson, C.; Etanidazole. Drugs Fut 1995, 20, 8, 772.
|
【2】
Lee, W.W.; Brown, J.M.; Martinez, A.P.; Cory, M.J. (US Department of Health & Human Services); Nitroimidazoles of low toxicity and high activity as radiosensitizers of hypoxic tumor cells. US 4371540 .
|
【3】
Beaman, A.G.; Duschinsky, R.; Tautz, W.P. (F. Hoffmann-La Roche AG); 2-Nitroimidazoles. US 3679698 .
|
【4】
Beaman, A.G.; Duschinsky, R.; Tautz, W.P. (F. Hoffmann-La Roche AG); Novel imidazole derivs. and a process for the manufacture thereof. GB 1138529 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(III) |
10258 |
methyl 2-(2-nitro-1H-imidazol-1-yl)acetate; Methyl 2-nitro-1-imidazoleacetate
|
22813-31-6 |
C6H7N3O4 |
详情 | 详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(B) The reaction of maleopimaric acid (I) with aqueous ammonia and heating at 170 C gives maleopimarimide (II), which by reaction with oxalyl chloride in benzene is converted into the corresponding acyl chloride (III). The reaction of (III) with morpholine (A) in benzene yields maleopimarimidyl morpholide (IV), which is finally condensed with ethanolamine (B) in refluxing methanol.
【1】
Danswan, G.W.; Ramm, P.J.; Matharu, S.; Taylor, J.B.; hepatoprotective agents. II. Maleopimaridyl morpholides. Arzneim-Forsch Drug Res 1976, 26, 12, 2190-92.
|
【2】
Thorpe, P.; Castaner, J.; RU 18492. Drugs Fut 1977, 2, 9, 623.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(A) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(I) |
40150 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-14,16-dioxo-15-oxapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-5-carboxylic acid
|
|
C24H32O5 |
详情 |
详情
|
(II) |
40151 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-14,16-dioxo-15-azapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-5-carboxylic acid
|
|
C24H33NO4 |
详情 |
详情
|
(III) |
40152 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-14,16-dioxo-15-azapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-5-carbonyl chloride
|
|
C24H32ClNO3 |
详情 |
详情
|
(IV) |
40153 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-5-(4-morpholinylcarbonyl)-15-azapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-14,16-dione
|
|
C28H40N2O4 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(B) The reaction of maleopimaric acid (I) with SOCl2 in benzene produces the corresponding acyl chloride (V), which is then condensed with morpholine (A) by means of Et3N in benzene yielding maleopimaryl morpholide (VI). Finally, (VI) is condensed with ethanolamine (B) in refluxing ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(A) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(I) |
40150 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-14,16-dioxo-15-oxapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-5-carboxylic acid
|
|
C24H32O5 |
详情 |
详情
|
(V) |
40155 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-14,16-dioxo-15-oxapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-5-carbonyl chloride
|
|
C24H31ClO4 |
详情 |
详情
|
(VI) |
40154 |
(1S,4R,5R,9R,10R,12R,13R,17R)-19-isopropyl-5,9-dimethyl-5-(4-morpholinylcarbonyl)-15-oxapentacyclo[10.5.2.0(1,10).0(4,9).0(13,17)]nonadec-18-ene-14,16-dione
|
|
C28H39NO5 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) HECNU can be prepared as follows (2): The reaction of 2-chloroethylisocyanate (I) with activated sodium azide yields 2-chloroethylcarbamoylazide (II). The preparation of N-(2-chloroethyl)-N-nitrosocarbamoylazide (III) was performed by adding 2-chloroethylcarbamoyiazide (III) to a suspension of anhydrous sodium acetate and nitrogen tetroxide in carbon tetrachloride. Reaction of N-(2-chloroethyl)-N-nitrosocarbamoylazide (III) with ethanolamine (IV) in isopropanol yields elmustine. The described synthetic approach offers a useful means to get the nitroso group attached to the required position.
【1】
Eisenbrand, G.; et al.; Some new congeners of the anticancer 1,2-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential. Z Krebsforsch 1976, 86, 279. |
【2】
Hansch, C.; et al.; Quantitative structure activity relationships of antineoplastic drugs: Nitrosoureas and triazenoimidazoles. Cancer Chemother Rep 1972, 56, 443.
|
【3】
Castaner, J.; Serradell, M.N.; Elmustine. Drugs Fut 1984, 9, 1, 18.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11237 |
1-Chloro-2-isocyanatoethane; 2-Chloroethyl isocyanate
|
1943-83-5 |
C3H4ClNO |
详情 | 详情
|
(II) |
29946 |
1-[(azidocarbonyl)amino]-2-chloroethane
|
|
C3H5ClN4O |
详情 |
详情
|
(III) |
24460 |
1-(2-chloroethyl)-2-oxo-1-hydrazinecarbonyl azide
|
|
C3H4ClN5O2 |
详情 |
详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) A new synthesis of miglitol has been reported:
Reaction of the bromoglycoside (I) with ethanolamine (II) by means of Zn and NaBH3CN in refluxing propanol/water gives the adduct (III), which is benzylated with benzyl chloride and NaH in DMF yielding compound (IV). The cyclization of (IV) by means of mercury trifluoroacetate in THF, followed by a treatment with KHCO3 and KBr affords a mixture of the diastereomeric organomercuric piperidines (V) and (VI) which are separated by chromatography. The desired diastereomer (VI) was treated with O2 and NaBH4 in DMF to give the protected piperidinemethanol (VII), which is finally debenzylated by hydrogenolysis with H2 over Pd/C in ethanol. The undesired diastereomer (V) can be recovered by Swern oxidation giving aldehyde (VIII), isomerization of (VIII) with DBU to provide aldehyde (IX) and reduction of (IX) to the already reported piperidinemethanol (VII).
【1】
Therisod, M.; Fouacea, S.; Lipophilic prodrugs of 1-deoxynojirimycin derivatives. Tetrahedron Lett 2000, 41, 38, 7313.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
42485 |
(2S,3S,4S,5R,6S)-3,4,5-tris(benzyloxy)-2-(bromomethyl)-6-methoxytetrahydro-2H-pyran; benzyl (2S,3R,4S,5S,6S)-4,5-bis(benzyloxy)-6-(bromomethyl)-2-methoxytetrahydro-2H-pyran-3-yl ether
|
|
C28H31BrO5 |
详情 |
详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
42486 |
2-[[(2S,3S,4R)-2,3,4-tris(benzyloxy)-5-hexenyl]amino]-1-ethanol
|
|
C29H35NO4 |
详情 |
详情
|
(IV) |
42487 |
N-[2-(benzyloxy)ethyl]-N-[(2S,3S,4R)-2,3,4-tris(benzyloxy)-5-hexenyl]amine; (2S,3S,4R)-2,3,4-tris(benzyloxy)-N-[2-(benzyloxy)ethyl]-5-hexen-1-amine
|
|
C36H41NO4 |
详情 |
详情
|
(V) |
42488 |
bromo([(2R,3R,4R,5S)-3,4,5-tris(benzyloxy)-1-[2-(benzyloxy)ethyl]piperidinyl]methyl)mercury
|
|
C36H40BrHgNO4 |
详情 |
详情
|
(VI) |
42489 |
bromo([(2S,3R,4R,5S)-3,4,5-tris(benzyloxy)-1-[2-(benzyloxy)ethyl]piperidinyl]methyl)mercury
|
|
C36H40BrHgNO4 |
详情 |
详情
|
(VII) |
42490 |
[(2R,3R,4R,5S)-3,4,5-tris(benzyloxy)-1-[2-(benzyloxy)ethyl]piperidinyl]methanol
|
|
C36H41NO5 |
详情 |
详情
|
(VIII) |
42491 |
(2R,3R,4R,5S)-3,4,5-tris(benzyloxy)-1-[2-(benzyloxy)ethyl]-2-piperidinecarbaldehyde
|
|
C36H39NO5 |
详情 |
详情
|
(IX) |
42492 |
(2S,3R,4R,5S)-3,4,5-tris(benzyloxy)-1-[2-(benzyloxy)ethyl]-2-piperidinecarbaldehyde
|
|
C36H39NO5 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(B) Ethyleneimine is reacted with tetrafluoro-1.4-benzoquinone (I) in the cold to form 2,5-diaziridinyl-3,6-difluoro-1-4-benzoquinone (II). The reaction with ethanolamine at room temperature results in BZQ, which is recrystallized from ethanol.
【1】
Chou, F.; et al.; Potential central nervous system antitumor agents. Aziridinylbenzoquinones. J Med Chem 1976, 19, 11, 1302.
|
【2】
Bosanquet, A.G.; BZQ. Drugs Fut 1986, 11, 1, 12.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
24122 |
2,3,5,6-tetrafluorobenzo-1,4-quinone
|
527-21-9 |
C6F4O2 |
详情 | 详情
|
(II) |
24123 |
2,5-di(1-aziridinyl)-3,6-difluorobenzo-1,4-quinone
|
|
C10H8F2N2O2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) The protection of ethanolamine (I) with trityl chloride (II) in isopropanol gives N-tritylethanolamine (III), which is condensed with ethyl 4-chloroacetoacetate (IV) by means of NaH in THF to yield ethyl 4-[2-(tritylamino)ethoxy]acetoacetate (V). The cyclization of (V) with 2-chlorobenzaldehyde (VI) and methyl 3-aminocrotonate (VII) in refluxing methanol affords the protected dihydropyridine (VIII), which, without isolation, is finally detritylated by a treatment with aqueous benzenesulfonic acid.
【1】
Furlan, B.; Copar, A.; Jeriha, A. (LEK Pharmaceutical and Chemical Co.); 3-Ethyl 5-methyl (+)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chloro-phenyl)-1,4-dihydro-6-methyl-6-methyl-3, 5-pyridinedicarboxylate. EP 0599220; US 5389654 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
48259 |
1-(2-chloro-1,1-diphenylethyl)benzene
|
|
C20H17Cl |
详情 |
详情
|
(III) |
48260 |
2-(tritylamino)-1-ethanol
|
|
C21H21NO |
详情 |
详情
|
(IV) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(V) |
48261 |
ethyl 3-oxo-4-[2-(tritylamino)ethoxy]butanoate
|
|
C27H29NO4 |
详情 |
详情
|
(VI) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VIII) |
48262 |
5-ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[[2-(tritylamino)ethoxy]methyl]-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C39H39ClN2O5 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(A) By reaction of 4-(p-fluorobenzoyl)piperidine (I) with 3-(2-chloroethyl)-2,4-(1H,3H)-quinazolinedione (II) by means of Na2CO3 in refluxing 4-methyl-2-pentanone.
The starting compounds are prepared as follows:
1) The Grignard reaction of N-benzyl-4-cyanopiperidine (III) with p-fluorophenylmagnesium bromide (IV) ethyl ether gives N-benzyl-4-p-fluorobenzoyl)piperidine (V), which by reaction with Na2CO3 and ethyl chloroformate (A) is converted into N-ethoxycarbonyl-4-(p-fluorobenzoyl)piperidine (VI). Finally, this compound is hydrolyzed with 48% HBr to give (I).
2) The reaction of ethyl anthranilate (VII) with ethyl chloroformate (A) in refluxing xylene gives ethyl 2-(ethoxycarbonylamino)benzoate (VIII), which is cyclized with 2-aminoethanol (B) at 170 C to afford 3-(2-hydroxyethyl)-2,4-(1H,3H)-quinazolinedione (IX). Finally, this compound is treated with SOCl2 in refluxing chloroform to afford (II).
【1】
Van Der, M.; Keninis, L.; Vandenberk, J.; Van Heertum, A. (Janssen Pharmaceutica NV); Piperidinylalkyl quinazoline compounds, composition and method of use. EP 0013612; JP 55105679; US 4335127 .
|
【2】
Blancafort, P.; Paton, D.M.; Serradell, M.N.; Castaner, J.; Ketanserin. Drugs Fut 1981, 6, 11, 684.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(B) |
11229 |
1-[(Chlorocarbonyl)oxy]ethane;ethyl carbonochloridate; Carbonchloridic acid ethyl ester;Ethyl chloroformate;Ethyl chlorocarbonate |
541-41-3 |
C3H5ClO2 |
详情 | 详情
|
(I) |
21497 |
(4-Fluorophenyl)(4-piperidinyl)methanone; 4-(4-Fluorobenzoyl)piperidine; 4-(p-Fluorobenzoyl)piperidine
|
56346-57-7 |
C12H14FNO |
详情 | 详情
|
(II) |
32277 |
3-(2-chloroethyl)-2,4(1H,3H)-quinazolinedione
|
5081-87-8 |
C10H9ClN2O2 |
详情 | 详情
|
(III) |
29013 |
1-benzyl-4-piperidinecarbonitrile
|
|
C13H16N2 |
详情 |
详情
|
(IV) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(V) |
29014 |
(1-benzyl-4-piperidinyl)(4-fluorophenyl)methanone
|
|
C19H20FNO |
详情 |
详情
|
(VI) |
29015 |
ethyl 4-(4-fluorobenzoyl)-1-piperidinecarboxylate
|
|
C15H18FNO3 |
详情 |
详情
|
(VII) |
32278 |
ethyl 2-aminobenzoate
|
87-25-2 |
C9H11NO2 |
详情 | 详情
|
(VIII) |
32279 |
ethyl 2-[(ethoxycarbonyl)amino]benzoate
|
|
C12H15NO4 |
详情 |
详情
|
(IX) |
32280 |
3-(2-hydroxyethyl)-2,4(1H,3H)-quinazolinedione
|
|
C10H10N2O3 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The reaction of 3-acetyl-6-methyl-3,4-dihydro-2H-pyran-2,4-dione (I) with ammonia gives 2,6-dimethylpyridin-4-ol (II), which is nitrated with HNO3/H2SO4 and treated with SOCl2 to yield 4-chloro-2,6-dimethyl-3-nitropyridine (III). The condensation of (III) with ethanolamine (IV) affords N-(2,6-dimethyl-3-nitropyridin-4-yl)ethanolamine (V), which is finally condensed with 1-(diphenylmethyl)piperazine (VI) by means of SOCl2 and treated with HCl to furnish the target trihydrochloride.
【1】
(Aventis SA); Pyridine derivs.. DE 3541428; EP 0224159; JP 1987129271; US 4792554 .
|
【2】
Elben, U.; SUBSTITUTED DIALKYLPYRIDINES AND THEIR N-OXIDES WITH AN ELECTRON-WITHDRAWING SUBSTITUENT. Drugs Fut 1989, 14, 10, 981.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
43660 |
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione
|
520-45-6 |
C8H8O4 |
详情 | 详情
|
(II) |
43661 |
2,6-dimethyl-4-pyridinol
|
|
C7H9NO |
详情 |
详情
|
(III) |
43662 |
4-chloro-2,6-dimethyl-3-nitropyridine
|
|
C7H7ClN2O2 |
详情 |
详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(V) |
43663 |
2-[(2,6-dimethyl-3-nitro-4-pyridinyl)amino]-1-ethanol
|
|
C9H13N3O3 |
详情 |
详情
|
(VI) |
20796 |
N-(Benzhydryl)piperazine; 1-Benzhydrylpiperazine; 1-(dibenzyl)piperazine
|
841-77-0 |
C17H20N2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) The synthesis of the optical enantiomers of mosapride has been described:
The reductocondensation of 4-fluorobenzaldehyde (I) with ethanolamine (II) by means of NaBH4 and NaHCO3 in refluxing methanol gives 2-(4-fluorobenzylamino)ethanol (III), which is condensed with epichlorohydrin (IV) to yield the diol (V). Compound (V), without isolation, is cyclized with conc. H2SO4 to afford 2-(chloromethyl)-4-(4-fluorobenzyl)morpholine (VI), which is treated with refluxing water-formamide to afford the corresponding methanol derivative (VII). Tosylation of (VII) with tosyl chloride and triethylamine/4-(dimethylamino)pyridine in dichloromethane gives the tosylate (VIII) as a racemic mixture. The optical resolution of (VIII) with N-(p-toluenesulfonyl)-L-glutamic acid in methanol affords the (S)-tosylate [(S)-IX] and the (R)-tosylate [(R)-IX]. The reaction of both [(S)-IX] and [(R)-IX] with sodium azide followed by reduction with bis(2-methoxyethoxy)aluminum hydride (vitride) gives the chiral amines [(S)-X] and [(R)-X], which are finally condensed with 4-amino-5-chloro-2-ethoxybenzoic acid (XI) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (WSC) in dichloromethane, yielding the (S)- and (R)-enantiomers of mosapride.
【1】
Morie, T.; Kato, S.; Harada, H.; Yoshida, N.; Matsumoto, J.; Synthesis and biological activities of the optical isomers of (±)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide (mosapride). Chem Pharm Bull 1994, 42, 4, 877. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
((S)-IX) |
12345 |
[(2S)-4-(4-fluorobenzyl)-1,4-oxazinan-2-yl]methyl phenylmethanesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
((R)-IX) |
12346 |
[(2R)-4-(4-fluorobenzyl)-1,4-oxazinan-2-yl]methyl phenylmethanesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
((R)-X) |
12347 |
[(2R)-4-(4-Fluorobenzyl)morpholinyl]methanamine; [(2R)-4-(4-Fluorobenzyl)morpholinyl]methylamine
|
|
C12H17FN2O |
详情 |
详情
|
((S)-X) |
12348 |
[(2S)-4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methylamine; [(2S)-4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methanamine
|
|
C12H17FN2O |
详情 |
详情
|
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
12334 |
2-[(4-Fluorobenzyl)amino]-1-ethanol
|
|
C9H12FNO |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
12341 |
1-Chloro-3-[(4-fluorobenzyl)(2-hydroxyethyl)amino]-2-propanol
|
|
C12H17ClFNO2 |
详情 |
详情
|
(VI) |
12342 |
2-(Chloromethyl)-4-(4-fluorobenzyl)morpholine
|
|
C12H15ClFNO |
详情 |
详情
|
(VII) |
12343 |
[4-(4-Fluorobenzyl)-2-morpholinyl]methanol
|
|
C12H16FNO2 |
详情 |
详情
|
(VIII) |
12344 |
[4-(4-fluorobenzyl)-2-morpholinyl]methyl 4-methylbenzenesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
(XI) |
12333 |
4-Amino-5-chloro-2-ethoxybenzoic acid
|
|
C9H10ClNO3 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(A) The esteritication of nicotinic acid (I) with methanol and HCl or H2SO4 yields the corresponding methyl ester (II), which is treated with ethanolamine (A) to afford N-(beta-hydroxyethyl)nicotinamide (III). Finally, this compound is transformed into the nitrate ester by the usual methods.
【1】
Masayoshi, S.; Solubilizing agents. V. Pyridinecarboxamides. Yakugaku Zasshi 1960, 80, 1706-12.
|
【2】
Thorpe, P.J.; Castaner, J.; SG-75. Drugs Fut 1979, 4, 2, 134.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
10752 |
Nicotinic acid; Niacin
|
59-67-6 |
C6H5NO2 |
详情 | 详情
|
(II) |
13980 |
methyl nicotinate; Nicotinic acid, methyl ester
|
93-60-7 |
C7H7NO2 |
详情 | 详情
|
(III) |
13982 |
N-(2-Hydroxyethyl)nicotinamide
|
|
C8H10N2O2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
In scheme 14476001a hexadecanol is reacted with phosphoroxy chloride in the presence of triethylamine in tetrahydrofuran with subsequent condensation with ethanolamine in dioxane/triethylamine. Hydrolysis with aqueous hydrochloric acid and methylation with dimethyl sulfate in the presence of potassium carbonate yields hexadecyl phosphocholine.
【1】
Schumacher, W.; Unger, C.; Berger, M.R.; Hilgard, P.; Eibl, H.J.; Schmahl, D.; Stekar, J.; Engel, J.; Nagel, G.; Hexadecylphocholine. Drugs Fut 1988, 13, 11, 948.
|
【2】
Kin, D.J.; Unger, C.; Berger, M.R.; Fleer, E.A.M.; Nagel, G.A.; Eibl, H.; Hexadecylphosphocholine, a new antineoplastic agent: cytotoxic properties in leukaemic cells. J Cancer Res Clin Oncol 1986, 111, 24.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
23090 |
1-hexadecanol
|
36653-82-4 |
C16H34O |
详情 | 详情
|
(II) |
23091 |
Dichlorophosphoric acid hexadecyl ester
|
|
C16H33Cl2O2P |
详情 |
详情
|
(III) |
23092 |
2-(hexadecyloxy)-1,3,2lambda(5)-oxazaphospholidin-2-one
|
|
C18H38NO3P |
详情 |
详情
|
(IV) |
23093 |
Phosphoric acid 2-aminoethyl hexadecyl diester inner salt
|
|
C19H40O4P |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(VI) By condensation of N-(2-hydroxyethyl)-N-[3-(4-nitrophenyl)propyl]amine (I) with 1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino]pyrimidine-2,4(1H,3H)-dione (II) by means of NaOH in hot ethanol or methanol.
The starting materials are obtained as follows:
1) The esterification of 3-(4-nitrophenyl)propanol (III) with p-toluenesulfonyl chloride (IV) by means of pyridine in chloroform gives the corresponding p-toluenesulfonate (V), which is then condensed with ethanolamine (VI) by heating at 100 C to afford amine (I).
2) The condensation of ethanolamine (VI) with 6-chloro-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (VII) by heating at 90 C, or by means of triethylamine in refluxing isopropanol, gives 6-(2-hydroxyethylamino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (VIII), which is then esterified with p-toluenesulfonyl chloride (IV) as before yielding pyrimidine (II).
【1】
Katakami, T.; Yokoyama, T.; Miyamoto, M.; Mori, H.; Kawauchi, N.; Nobori, T.; Sannohe, K.; Kamiya, J.; Ishii, M.; Yoshihara, K. (Mitsui Chemicals, Inc.); Pyrimidinedione deriv. cpds., method of producing the same and antiarrhythmic agents containing the same. AU 8943869; EP 0369627; JP 1991112948; JP 1991173873; US 5008267 . |
【2】
Kaiho, T.; Mori, H.; Miyamoto, M.; Nobori, T.; Yokoyama, T.; Kawauchi, N.; Katakami, T.; San-nohe, K.; Synthesis and pharmacological studies of N-substituted 6-[(2-aminoethyl)amino]-1,3-dimethyl-2,4(1H,3H) pyrimidinediones, novel class III antiarrhythmic agents. J Med Chem 1992, 35, 18, 3325-30. |
【3】
Castaner, J.; Prous, J.; MS-551. Drugs Fut 1993, 18, 3, 226.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13972 |
2-[[3-(4-Nitrophenyl)propyl]amino]-1-ethanol
|
|
C11H16N2O3 |
详情 |
详情
|
(II) |
13973 |
2-[(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinyl)amino]ethyl 4-methylbenzenesulfonate
|
|
C15H19N3O5S |
详情 |
详情
|
(III) |
13974 |
3-(4-Nitrophenyl)-1-propanol
|
|
C9H11NO3 |
详情 |
详情
|
(IV) |
13975 |
p-Toluenesulfonyl chloride;p-tosyl chloride;Toluene-4-sulfonyl chloride;4-Toluene sulfochloride;tosyl chloride; 4-Methylbenzenesulfonyl chloride |
98-59-9 |
C7H7ClO2S |
详情 | 详情
|
(V) |
13976 |
3-(4-nitrophenyl)propyl 4-methylbenzenesulfonate
|
|
C16H17NO5S |
详情 |
详情
|
(VI) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(VII) |
13978 |
6-Chloro-1,3-dimethyluracil; 6-Chloro-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
|
6972-27-6 |
C6H7ClN2O2 |
详情 | 详情
|
(VIII) |
13979 |
6-[(2-Hydroxyethyl)amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
|
|
C8H13N3O3 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(II) The starting products are prepared as follows: The reaction of pyridine-3-carboxylic acid methyl ester (I) with ethanolamine (II) gives the 2-hydroxyethylamide (III), which by reaction with diketene in THF yields the corresponding acetoacetic ester (V). The reaction of (V) with ammonia in THF affords the expected 3-aminocrotonate ester (VI).
【1】
Ogawa, T.; Hatayama, K.; Maeda, H.; Kita, Y.; Mild and facile cleavage of 2-cyanoethyl ester using sodium sulfide or tetrabutylammonium fluoride. Synthesis of 1,4-dihydropyridine monocarboxylic acids and unsymmetrical 1,4-dihydropyridine dicarboxylates. Chem Pharm Bull 1994, 42, 8, 1579-89. |
【2】
Mealy, N.; Martel, A.M.; Castaner, J.; CD-832.HCl. Drugs Fut 1996, 21, 12, 1221.
|
【3】
Kelly, R.C.; Martin, D.G.; Aristoff, P.A. (Pharmacia Corp.); Novel CC-1065 analogs. AU 8812290; EP 0340243; WO 8804659 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13980 |
methyl nicotinate; Nicotinic acid, methyl ester
|
93-60-7 |
C7H7NO2 |
详情 | 详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
13982 |
N-(2-Hydroxyethyl)nicotinamide
|
|
C8H10N2O2 |
详情 |
详情
|
(IV) |
11367 |
4-Methylene-2-oxetanone; Acetyl ketene
|
674-82-8 |
C4H4O2 |
详情 | 详情
|
(V) |
13984 |
2-[(3-pyridinylcarbonyl)amino]ethyl 3-oxobutanoate
|
|
C12H14N2O4 |
详情 |
详情
|
(VI) |
13985 |
2-[(3-pyridinylcarbonyl)amino]ethyl (E)-3-amino-2-butenoate
|
|
C12H15N3O3 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(I) Protection of the amino group of 2-aminoethanol (I) with di-tert-butyldicarbonate, followed by reaction with phenylchlorocarbonate, gives 2-(tert-butoxycarbonylamino)ethylphenylcarbonate (II), which on reaction in refluxing 1,2,3,4-tetrahydroisoquinoline (III) yields 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 2-(tert-butoxycarbonylamino)ethyl ester (IV). Compound (IV) is deprotected with HCl in methanol to give 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 2-aminoethyl ester (V), which is coupled with 3-(N-tert-butoxycarbonyl-N-phenylamino)propanoic acid (VI) in the presence of dicyclohexylcarbodiimide to afford N-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethyl]-3-(N'-tert-butoxycarbonyl-N'-phenylamino)propanamide (VII). Deprotection of (VII) with HCl in methanol gives N-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethyl]-3-(phenylamino)propanamide (VIII), which is acylated with 5-bromonicotinoyl chloride hydrochloride (IX) in the presence of triethylamine to yield 3-bromo-5-[N-phenyl-N-[2-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethylcarbamoyl]ethyl]carbamoyl]pyridine (X). Compound (X) is finally reacted with iodopropane and iodide anion exchanged by nitrate with IRA-410 (NO3-).
【1】
Tsushima, S.; Takatani, M.; Nishikawa, K. (Takeda Chemical Industries, Ltd.); Pyridinium nitrate, its production and use. EP 0382380; JP 1990275876; US 4981860 .
|
【2】
Mealy, N.; Prous, J.; Castaner, J.; TCV-309. Drugs Fut 1993, 18, 8, 721.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
14123 |
2-[(tert-butoxycarbonyl)amino]ethyl phenyl carbonate
|
|
C14H19NO5 |
详情 |
详情
|
(III) |
14124 |
1,2,3,4-Tetrahydroisoquinoline
|
91-21-4 |
C9H11N |
详情 | 详情
|
(IV) |
14125 |
2-[(tert-butoxycarbonyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C17H24N2O4 |
详情 |
详情
|
(V) |
14126 |
2-aminoethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C12H16N2O2 |
详情 |
详情
|
(VI) |
14127 |
3-[(tert-Butoxycarbonyl)anilino]propionic acid
|
|
C14H19NO4 |
详情 |
详情
|
(VII) |
14128 |
2-([3-[(tert-butoxycarbonyl)anilino]propanoyl]amino)ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C26H33N3O5 |
详情 |
详情
|
(VIII) |
14129 |
2-[(3-anilinopropanoyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C21H25N3O3 |
详情 |
详情
|
(IX) |
14130 |
5-Bromonicotinoyl chloride
|
39620-02-5 |
C6H3BrClNO |
详情 | 详情
|
(X) |
14131 |
2-[(3-[[(5-bromo-3-pyridinyl)carbonyl]anilino]propanoyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C27H27BrN4O4 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XIV) Displacement of the benzylic bromide (XIII) with concomitant hydrolysis of the phenolic acetate with ethanolamine (XIV) gave amine (XV). A further aromatic bromide of (XV) was displaced with hot 1,3-propanediamine (XVI), yielding adduct (XVII). Hydrogenolysis of the remaining bromide of (XVII) using Pd/C furnished (XVIII). Finally, methyl ether cleavage in (XVIII) with hot HCl provided the title compound
【1】
Mimura, T.; Kato, N.; Sugaya, T.; Ikuta, M.; Kato, S.; Kuge, Y.; Tomioka, S.; Kasai, M.; An efficient synthesis of a new class of DNA intercalating antitumor 7,10-dihydroxy-6H-pyrazolo[4,5,1-de]acridin-6-ones. Synthesis (Stuttgart) 1999, 6, 947.
|
【2】
Mimura, Y.; Shida, Y.; Kasai, M.; Ashizawa, T.; Gomi, K. (Kyowa Hakko Kogyo Co., Ltd.); Pyrazoloacridone derivs.. EP 0487097; JP 1993001064; US 5220026 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
60010 |
5,8-dibromo-2-(bromomethyl)-7-methoxy-6-oxo-6H-pyrazolo[4,5,1-de]acridin-10-yl acetate
|
|
C18H11Br3N2O4 |
详情 |
详情
|
(XIV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XV) |
60011 |
5,8-dibromo-10-hydroxy-2-{[(2-hydroxyethyl)amino]methyl}-7-methoxy-6H-pyrazolo[4,5,1-de]acridin-6-one
|
|
C18H15Br2N3O4 |
详情 |
详情
|
(XVI) |
19331 |
3-aminopropylamine; 1,3-propanediamine
|
109-76-2 |
C3H10N2 |
详情 | 详情
|
(XVII) |
60012 |
5-[(3-aminopropyl)amino]-8-bromo-10-hydroxy-2-{[(2-hydroxyethyl)amino]methyl}-7-methoxy-6H-pyrazolo[4,5,1-de]acridin-6-one
|
|
C21H24BrN5O4 |
详情 |
详情
|
(XVIII) |
60013 |
5-[(3-aminopropyl)amino]-10-hydroxy-2-{[(2-hydroxyethyl)amino]methyl}-7-methoxy-6H-pyrazolo[4,5,1-de]acridin-6-one
|
|
C21H25N5O4 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(VII) The synthesis of BBR-3438 has been described: The cyclization of 6-chloro-9-fluorobenz[g]isoquinoline-5,10-quinone (I) with 2-hydroxyethylhydrazine (II) in hot pyridine gives 2-(2-hydroxyethyl)-5-chloroindazolo[4,3-gh]isoquinolin-6(2H)-one (III), which is condensed with N-(2-aminoethyl)-N-methylcarbamic acid tert-butyl ester (IV) in hot pyridine yielding the corresponding 5-[2-[N-(tert-butoxycarbonyl)-N-methylamino]ethylamino] derivative (V). The mesylation of the OH group of (V) with mesyl chloride and triethylamine in dichloromethane affords the mesylate (VI), which is condensed with hot ethanolamine (VII) to give the protected compound (VIII). Finally, this compound is deprotected with HCl yielding BBR-3438.
【1】
Krapcho, A.P.; Menta, E.; Oliva, A.; Di Domenico, R.; Fiocchi, L.; Maresch, M.E.; Gallagher, C.E.; Hacker, M.P.; Beggiolin, G.; Giuliani, F.C.; Pezzoni, G.; Spinelli, S.; Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles). J Med Chem 1998, 41, 27, 5429. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24950 |
6-chloro-9-fluorobenzo[g]isoquinoline-5,10-dione
|
|
C13H5ClFNO2 |
详情 |
详情
|
(II) |
24951 |
2-hydrazino-1-ethanol
|
109-84-2 |
C2H8N2O |
详情 | 详情
|
(III) |
24952 |
5-chloro-2-(2-hydroxyethyl)indazolo[4,3-gh]isoquinolin-6(2H)-one
|
|
C15H10ClN3O2 |
详情 |
详情
|
(IV) |
24953 |
N-(2-Aminoethyl)-N-methylcarbamic acid tert-butyl ester; tert-butyl 2-aminoethyl(methyl)carbamate
|
121492-06-6 |
C8H18N2O2 |
详情 | 详情
|
(V) |
24954 |
tert-butyl 2-[[2-(2-hydroxyethyl)-6-oxo-2,6-dihydroindazolo[4,3-gh]isoquinolin-5-yl]amino]ethyl(methyl)carbamate
|
|
C23H27N5O4 |
详情 |
详情
|
(VI) |
24955 |
2-[5-([2-[(tert-butoxycarbonyl)(methyl)amino]ethyl]amino)-6-oxoindazolo[4,3-gh]isoquinolin-2(6H)-yl]ethyl methanesulfonate
|
|
C24H29N5O6S |
详情 |
详情
|
(VII) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(VIII) |
24957 |
tert-butyl 2-[(2-[2-[(2-hydroxyethyl)amino]ethyl]-6-oxo-2,6-dihydroindazolo[4,3-gh]isoquinolin-5-yl)amino]ethyl(methyl)carbamate
|
|
C25H32N6O4 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(VII) The synthesis of BBR-3409 has been described: The cyclization of 6-chloro-9-fluorobenz[g]isoquinoline-5,10-quinone (I) with 2-hydroxyethylhydrazine (II) in hot pyridine gives 2-(2-hydroxyethyl)-5-chloroindazolo[4,3-gh]isoquinolin-6(2H)-one (III), which is condensed with N-(2-aminoethyl)-N,N-dimethylamine (IV) in hot pyridine yielding the corresponding compound (V). The mesylation of the OH group of (V) with mesyl chloride and triethylamine in dichloromethane affords the mesylate (VI), which is condensed with hot ethanolamine (VII) to give BBR-3409.
【1】
Krapcho, A.P.; Menta, E.; Oliva, A.; Di Domenico, R.; Fiocchi, L.; Maresch, M.E.; Gallagher, C.E.; Hacker, M.P.; Beggiolin, G.; Giuliani, F.C.; Pezzoni, G.; Spinelli, S.; Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles). J Med Chem 1998, 41, 27, 5429. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24950 |
6-chloro-9-fluorobenzo[g]isoquinoline-5,10-dione
|
|
C13H5ClFNO2 |
详情 |
详情
|
(II) |
24951 |
2-hydrazino-1-ethanol
|
109-84-2 |
C2H8N2O |
详情 | 详情
|
(III) |
24952 |
5-chloro-2-(2-hydroxyethyl)indazolo[4,3-gh]isoquinolin-6(2H)-one
|
|
C15H10ClN3O2 |
详情 |
详情
|
(IV) |
14881 |
N-(2-aminoethyl)-N,N-dimethylamine; N(1),N(1)-dimethyl-1,2-ethanediamine; 2-Dimethylaminoethylamine
|
108-00-9 |
C4H12N2 |
详情 | 详情
|
(V) |
26315 |
5-[[2-(dimethylamino)ethyl]amino]-2-(2-hydroxyethyl)indazolo[4,3-gh]isoquinolin-6(2H)-one
|
|
C19H21N5O2 |
详情 |
详情
|
(VI) |
26316 |
2-[5-[[2-(dimethylamino)ethyl]amino]-6-oxoindazolo[4,3-gh]isoquinolin-2(6H)-yl]ethyl methanesulfonate
|
|
C20H23N5O4S |
详情 |
详情
|
(VII) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(I) The reductocondensation of ethanolamine (I) with 3-methylbenzaldehyde (II) by means of NaBH4 gives N-(3-methylbenzyl)ethanolamine (III), which is treated with SOCl2 to yield the 2-chloroethyl derivative (IV). The reaction of (IV) with methylamine (V) affords N-methyl-N'-(3-methylbenzyl)ethane-1,2-diamine (VI), which is condensed with the pyrazole-carboxamide derivative (VII) to provide the unstable compound (VIII)?? (IX). The reduction of (IX) with NaBH4 gives the racemic amide (X), which is submitted to optical resolution by preferential crystallization to yield the (R)-isomer (XI) (1,2). The hydrogenation of (XI) with H2 over Pd/C in ethanol affords the debenzylated compound (XII), which is alkylated by reductocondensation with acetaldehyde (XIII) and NaBH4 in methanol to provide the chiral N-(1-ethyl-4'-methylperhydro-1,4-diazepin-6-(R)-yl)-1H-pyrazole-3-carboxamide (XIV). Finally, this compound is treated with refluxing aqueous HCl to give the corresponding 6(R)-amino derivative (XV).
【2】
Hirokawa, Y.; et al.; Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist. Chem Pharm Bull 2002, 50, 7, 941. |
【1】
Harada, H.; et al.; Synthesis and resolution of (±)-N-[1-methyl-4-(3-methylbenzyl)hexahydro-1H-1,4-diazepin-6-yl]-1H-indazole-3-carboxamide by preferential crystallization. Tetrahedron Asymmetry 1997, 8, 14, 2367. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
41077 |
3-methylbenzaldehyde
|
620-23-5 |
C8H8O |
详情 | 详情
|
(III) |
58175 |
2-[(3-methylbenzyl)amino]-1-ethanol
|
|
C10H15NO |
详情 |
详情
|
(IV) |
58176 |
2-chloro-N-(3-methylbenzyl)-1-ethanamine; N-(2-chloroethyl)-N-(3-methylbenzyl)amine
|
|
C10H14ClN |
详情 |
详情
|
(V) |
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
(VI) |
54009 |
N~1~-methyl-N~2~-(3-methylbenzyl)-1,2-ethanediamine; N-methyl-N-{2-[(3-methylbenzyl)amino]ethyl}amine
|
n/a |
C11H18N2 |
详情 | 详情
|
(VII) |
58177 |
ethyl 3-{[(1-formylvinyl)amino]carbonyl}-1H-indazole-1-carboxylate
|
|
C14H13N3O4 |
详情 |
详情
|
(VIII) |
58178 |
ethyl 3-({[1-formyl-2-(methyl{2-[(3-methylbenzyl)amino]ethyl}amino)ethyl]amino}carbonyl)-1H-indazole-1-carboxylate
|
|
C25H31N5O4 |
详情 |
详情
|
(IX) |
58179 |
6-({[1-(ethoxycarbonyl)-1H-indazol-3-yl]carbonyl}amino)-4-methyl-1-(3-methylbenzyl)-3,4,5,6-tetrahydro-2H-1,4-diazepin-1-ium
|
|
C25H30N5O3 |
详情 |
详情
|
(X) |
58180 |
N-[1-methyl-4-(3-methylbenzyl)-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide
|
|
C22H27N5O |
详情 |
详情
|
(XI) |
58181 |
N-[(6S)-1-methyl-4-(3-methylbenzyl)-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide
|
|
C22H27N5O |
详情 |
详情
|
(XII) |
58182 |
N-[(6S)-1-methyl-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide
|
|
C14H19N5O |
详情 |
详情
|
(XIII) |
11974 |
Acetaldehyde
|
75-07-0 |
C2H4O |
详情 | 详情
|
(XIV) |
58183 |
N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide
|
|
C16H23N5O |
详情 |
详情
|
(XV) |
17802 |
(6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine
|
|
C8H19N3 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(X) In an alternative procedure, 3-chloroaniline (I) was acylated with chloroacetyl chloride (V) to produce chloroacetamide (IX). Displacement of the chloride group of (IX) with ethanolamine (X) gave rise to the amide alcohol (XI), which was then cyclized to the piperazinone (VIII) under Mitsunobu conditions.
【1】
Cowen, J.A.; Askin, D.; McWilliams, J.C.; Maligres, P.E.; McCauley, J.A. (Merck & Co., Inc.); Process for making farnesyl-protein transferase inhibitors. WO 0001691 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25239 |
3-chloroaniline; 3-chlorophenylamine
|
108-42-9 |
C6H6ClN |
详情 | 详情
|
(V) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(VIII) |
47289 |
1-(3-chlorophenyl)-2-piperazinone
|
|
C10H11ClN2O |
详情 |
详情
|
(IX) |
47290 |
2-chloro-N-(3-chlorophenyl)acetamide
|
|
C8H7Cl2NO |
详情 |
详情
|
(X) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XI) |
47291 |
N-(3-chlorophenyl)-2-[(2-hydroxyethyl)amino]acetamide
|
|
C10H13ClN2O2 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(X) The acetylation of 5-bromopyridine-2-amine (I) with acetic anhydride in AcOH gives the expected amide (II), which is alkylated with ethylene by means of palladium acetate, tri p-tolylphosphine and triethylamine in hot acetonitrile to yield N-(5-vinylpyridin-2-yl)acetamide (III). The regioselective dihydroxylation of the vinyl group of (III) with AD-Mix-B in tert-butanol affords N-[5-(1(R),2-dihydroxyethyl)pyridin-2-yl]acetamide (IV), which is monotosylated with Ts-Cl in cool pyridine to give the tosylate (V). The reaction of (V) with potassium tert.-butoxide in THF yields the epoxide (VI), which is condensed with 2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide (VII) in hot toluene/DMSO to provide the expected addition product (VIII). Finally, this compound is treated with 6N HCl on a steam bath.
The intermediate 2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide (VII) has been obtained as follows: The reaction of benzyl chloroformate (IX) with ethanolamine (X) by means of NaHCO3 in water gives the carbamate (XI), which is condensed with 2-(4-hydroxyphenyl)-N-methylacetamide (XII) (obtained by reaction of the corresponding methyl ester (XIII) with methylamine), by means of PPh3 and diisopropyl azodicarboxylate (DIAD) in THF yielding the intermediate (XIV). Finally, this compound is submitted to elimination of the carbamate protecting group by hydrogenation with H2 over Pd/C in methanol to provide the target intermediate (VII).
【1】
Dow, R.L. (Pfizer Inc.); beta-Adrenergic agonists to reduce a wasting condition. EP 0887079 .
|
【2】
Devries, K.M.; Dow, R.L.; Wright, S.W. (Pfizer Inc.); Process for substd. pyridines. EP 0938476; WO 9821184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
32490 |
N-(5-bromo-2-pyridinyl)acetamide
|
|
C7H7BrN2O |
详情 |
详情
|
(III) |
32491 |
N-(5-vinyl-2-pyridinyl)acetamide
|
|
C9H10N2O |
详情 |
详情
|
(IV) |
32492 |
N-[5-[(1R)-1,2-dihydroxyethyl]-2-pyridinyl]acetamide
|
|
C9H12N2O3 |
详情 |
详情
|
(V) |
32493 |
(2R)-2-[6-(acetamido)-3-pyridinyl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C16H18N2O5S |
详情 |
详情
|
(VI) |
32494 |
N-[5-[(2R)oxiranyl]-2-pyridinyl]acetamide
|
|
C9H10N2O2 |
详情 |
详情
|
(VII) |
32495 |
2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide
|
|
C11H16N2O2 |
详情 |
详情
|
(VIII) |
32496 |
2-[4-[2-([(2R)-2-[6-(acetamido)-3-pyridinyl]-2-hydroxyethyl]amino)ethoxy]phenyl]-N-methylacetamide
|
|
C20H26N4O4 |
详情 |
详情
|
(IX) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(X) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XI) |
32497 |
benzyl 2-hydroxyethylcarbamate
|
77987-49-6 |
C10H13NO3 |
详情 | 详情
|
(XII) |
32498 |
2-(4-hydroxyphenyl)-N-methylacetamide
|
|
C9H11NO2 |
详情 |
详情
|
(XIII) |
15822 |
Methyl 4-hydroxyphenylacetate; methyl 2-(4-hydroxyphenyl)acetate
|
14199-15-6 |
C9H10O3 |
详情 | 详情
|
(XIV) |
32499 |
benzyl 2-[4-[2-(methylamino)-2-oxoethyl]phenoxy]ethylcarbamate
|
|
C19H22N2O4 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(VI) The cyclization of 5,6-diamino-1-propylpyrimidine-2,4(1H,3H)-dione (I) with 4-bromobenzoic acid (II) by means of EDC and HOBT in DMF gives 8-(4-bromophenyl)-3-propylxanthine (III), which is treated with P2S5 in refluxing pyridine to yield the 6-thioxanthine (IV). The reaction of (IV) with Me-I and NaOH in ethanol affords the methylsulfanylpurin-2-one (V), which is treated with ethanolamine (VI) in DMSO at 150 C to provide the 2-hydroxyethylamino derivative (VII). Finally, this compound is cyclized by means of SOCl2 in refluxing chloroform to provide the target imidazopurine.
【1】
Tsumuki, H.; Saki, M.; Nonaka, H.; Ichimura, M.; Shimada, J.; Suzuki, F.; Ichikawa, S.; Kosaka, N. (Kyowa Hakko Kogyo Co., Ltd.); Fused purine derivs.. EP 0884318; US 6306847; WO 9815555 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20546 |
5,6-diamino-1-propyl-2,4(1H,3H)-pyrimidinedione
|
|
C7H12N4O2 |
详情 |
详情
|
(II) |
60207 |
4-bromo-1,3-cyclohexadiene-1-carboxylic acid
|
|
C7H7BrO2 |
详情 |
详情
|
(III) |
60208 |
8-(4-bromophenyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione
|
|
C14H13BrN4O2 |
详情 |
详情
|
(IV) |
60209 |
8-(4-bromophenyl)-3-propyl-6-thioxo-1,3,6,7-tetrahydro-2H-purin-2-one
|
|
C14H13BrN4OS |
详情 |
详情
|
(V) |
60210 |
8-(4-bromophenyl)-6-(methylsulfanyl)-3-propyl-3,7-dihydro-2H-purin-2-one
|
|
C15H15BrN4OS |
详情 |
详情
|
(VI) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(VII) |
60211 |
8-(4-bromophenyl)-6-[(2-hydroxyethyl)amino]-3-propyl-3,7-dihydro-2H-purin-2-one
|
|
C16H18BrN5O2 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(I) Acid-catalyzed condensation of ethanolamine (I) with urea (II) produced oxazolidinone (III). Subsequent reaction of (III) with triethyloxonium fluoborate yielded ethoxyoxazoline (IV). This was finally condensed with 2-(3,4-dimethoxyphenyl)- ethylamine to afford the title compound, which was isolated as the hydrochloride salt.
【1】
Xu, J.Y.; et al.; Synthesis of imidazoline, oxazoline derivatives and antihypertensive activity. J Chin Pharm Univ 1998, 29, 5, 336.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
19310 |
urea
|
57-13-6 |
CH4N2O |
详情 | 详情
|
(III) |
21456 |
1,3-oxazolidin-2-one
|
497-25-6 |
C3H5NO2 |
详情 | 详情
|
(IV) |
25692 |
4,5-dihydro-1,3-oxazol-2-yl ethyl ether; 2-ethoxy-4,5-dihydro-1,3-oxazole
|
|
C5H9NO2 |
详情 |
详情
|
(V) |
10098 |
2-(3,4-Dimethoxyphenyl)-1-ethanamine; 3,4-Dimethoxyphenethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine
|
120-20-7 |
C10H15NO2 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(A) Asymmetric dihydroxylation of intermeddiate silylated olefin (XII) employing potassium ferricyanide in the presence of osmium tetraoxide and the chiral auxiliary hydroquinidine 1,4-phthalazindiyl diether produced diol (XVIII). After conversion of the primary hydroxyl group of (XVIII) to the corresponding tosylate (XIX), displacement with ethanolamine yielded hydroxy amine (XX). Protection of (XX) as the Boc derivative (XXI), followed by cyclization under Mitsunobu conditions gave rise to morpholine (XXII). The Boc and silyl groups of (XXII) were then deprotected with HCl in dioxan, and the deprotected morpholine (XXIII) was acylated with 3,4,5-trimethoxybenzoyl chloride (XXIV) to produce amide (XXV). The alcohol group of (XXV) was then converted to mesylate (XXVI) using methanesulfonyl chloride and triethylamine. Optionally, the alchohol group was subjected to Swern oxidation, affording aldehyde (XXVII).
【1】
Kurata, H.; Ito, K.; Nakajima, K.; Yamaguchi, T.; Ishibashi, K.; Fukuzawa, T.; Nishi, T. (Sankyo Co., Ltd.); Azaheterocyclic cpds. having tachykinin receptor antagonist activity; NK1 and NK2. EP 0776893; JP 1998152478; JP 1998182649; JP 1998182650 .
|
【2】
Nishi, T.; Yamaguchi, T. (Sankyo Co., Ltd.); Salts of optically active sulfoxide deriv.. EP 0987269; JP 1999043490; WO 9854191 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XII) |
38430 |
tert-butyl[[3-(3,4-dichlorophenyl)-3-butenyl]oxy]dimethylsilane; tert-butyl(dimethyl)silyl 3-(3,4-dichlorophenyl)-3-butenyl ether
|
|
C16H24Cl2OSi |
详情 |
详情
|
(XVIII) |
38435 |
(2R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(3,4-dichlorophenyl)-1,2-butanediol
|
|
C16H26Cl2O3Si |
详情 |
详情
|
(XIX) |
38436 |
(2R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(3,4-dichlorophenyl)-2-hydroxybutyl 4-methylbenzenesulfonate
|
|
C23H32Cl2O5SSi |
详情 |
详情
|
(XX) |
38437 |
(2R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(3,4-dichlorophenyl)-1-[(2-hydroxyethyl)amino]-2-butanol
|
|
C18H31Cl2NO3Si |
详情 |
详情
|
(XXI) |
38438 |
tert-butyl (2R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(3,4-dichlorophenyl)-2-hydroxybutyl(2-hydroxyethyl)carbamate
|
|
C23H39Cl2NO5Si |
详情 |
详情
|
(XXII) |
38439 |
tert-butyl (2R)-2-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-2-(3,4-dichlorophenyl)-4-morpholinecarboxylate
|
|
C23H37Cl2NO4Si |
详情 |
详情
|
(XXIII) |
38440 |
2-[(2R)-2-(3,4-dichlorophenyl)morpholinyl]-1-ethanol
|
|
C12H15Cl2NO2 |
详情 |
详情
|
(XXIV) |
13571 |
3,4,5Ttrimethoxybenzoyl chloride
|
4521-61-3 |
C10H11ClO4 |
详情 | 详情
|
(XXV) |
38441 |
[(2R)-2-(3,4-dichlorophenyl)-2-(2-hydroxyethyl)morpholinyl](3,4,5-trimethoxyphenyl)methanone
|
|
C22H25Cl2NO6 |
详情 |
详情
|
(XXVI) |
38442 |
2-[(2R)-2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholinyl]ethyl methanesulfonate
|
|
C23H27Cl2NO8S |
详情 |
详情
|
(XXVII) |
38443 |
2-[(2R)-2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholinyl]acetaldehyde
|
|
C22H23Cl2NO6 |
详情 |
详情
|
合成路线29
该中间体在本合成路线中的序号:
(II) The reaction of 3-chloroaniline (I) with ethanolamine (II) by means of 47% HBr by heating at 170 C gives N-(3-chlorophenyl)ethylenediamine (III), which is condensed with ethyl 2-bromopropionate (IV) by means of triethylamine in refluxing toluene yielding the alanine derivative (V). The cyclization of (V) with refluxing 2N HCl affords the piperazinone (VI), which is reduced with LiAlH4 in ethyl ether providing 1-(3-chlorophenyl)-3-methylpiperazine (VII). The alkylation of (VII) with 1-bromo-3-chloropropane (VIII) by means of NaOH in acetone/water gives 4-(3-chlorophenyl)-1-(3-chloropropyl)-2-methylpiperazine (IX), which is condensed with the sodium salt of 1,2,4-triazolo[4,3-a]pyridin-3(2H)-one (X) in refluxing xylene/isobutanol yielding the target compound as a racemic mixture (XI). Finally, this compound is submitted to optical resolution with L-(+)-tartaric acid (XII).
【1】
Giannangeli, M.; Gazzolla, N.; Luparini, M.R.; Magnani, M.; Mabilia, M.; Picconi, G.; Tomaselli, M.; Baiocchi, L.; Effect of modifications of the alkylpiperazine moiety of trazodone on 5HT2A and alpha1 receptor binding affinity. J Med Chem 1999, 42, 3, 336. |
【2】
Baiocchi, L.; Cioli, V. (Angelini Group); Pharmacologically active enantiomers. EP 0707587; JP 1996512036; WO 9501354 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25239 |
3-chloroaniline; 3-chlorophenylamine
|
108-42-9 |
C6H6ClN |
详情 | 详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
34091 |
N(1)-(3-chlorophenyl)-1,2-ethanediamine; N-(2-aminoethyl)-N-(3-chlorophenyl)amine
|
|
C8H11ClN2 |
详情 |
详情
|
(IV) |
19460 |
ethyl 2-bromopropanoate; 2-Bromopropionic acid ethyl ester
|
535-11-5 |
C5H9BrO2 |
详情 | 详情
|
(V) |
28373 |
ethyl 2-[[2-(3-chloroanilino)ethyl]amino]propanoate
|
|
C13H19ClN2O2 |
详情 |
详情
|
(VI) |
28374 |
1-(3-chlorophenyl)-3-methyl-2-piperazinone
|
|
C11H13ClN2O |
详情 |
详情
|
(VII) |
28375 |
1-(3-chlorophenyl)-3-methylpiperazine
|
|
C11H15ClN2 |
详情 |
详情
|
(VIII) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(IX) |
28376 |
4-(3-chlorophenyl)-1-(3-chloropropyl)-2-methylpiperazine
|
|
C14H20Cl2N2 |
详情 |
详情
|
(X) |
28377 |
[3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl]sodium
|
|
C6H4N3NaO |
详情 |
详情
|
(XI) |
28378 |
2-[3-[4-(3-chlorophenyl)-2-methyl-1-piperazinyl]propyl][1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
|
|
C20H24ClN5O |
详情 |
详情
|
(XII) |
28379 |
(2R,3R)-2,3-dihydroxybutanedioic acid; L-Tartaric acid; (2R,3R)-2,3-dihydroxysuccinic acid
|
87-69-4 |
C4H6O6 |
详情 | 详情
|
合成路线30
该中间体在本合成路线中的序号:
Diethyl malonate (I) was alkylated with 2-bromoethyl ethyl ether (II) in the presence of NaOEt to provide diethyl 2-(ethoxyethyl)malonate (III). Treatment of 2-chloronitrobenzene (IV) with 2,2,2-trifluoroethanol (V) afforded the trifluoroethyl ether (VI). Subsequent reduction of the nitro group of (VI) by means of iron in acetic acid gave aniline (VII), which was condensed with malonate (III) in refluxing diphenyl ether, yielding furoquinoline (VIII). Further reaction of (VIII) with o-toluidine (IX) in boiling diethylene glycol produced the tetrahydropyrroloquinoline (X). Aromatization of the pyrrole ring of (X) to give (XI) was achieved by dehydrogenation in diphenyl ether in the presence of Pd/C. Chloroquinoline (XII) was then obtained by chlorination of (XI) with POCl3. Finally, displacement of the chlorine atom of (XII) by means of ethanolamine at 180 C furnished the title compound.
【1】
Kim, H.-J.; Kim, S.-S.; Yoo, Y.-K.; Kang, S.-K.; Cheon, H.-G.; Choi, J.-K.; Yum, E.-K. (Korea Research Institute of Chemical Technology); Pyrrolo[3,2-c]quinoline derivs. containing haloalkoxy group and pharmaceutically acceptable salts thereof. CA 2268166; EP 0966466; JP 2000504352; US 6011044; WO 9909029 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
34659 |
2-bromoethyl ethyl ether; 1-bromo-2-ethoxyethane
|
592-55-2 |
C4H9BrO |
详情 | 详情
|
(III) |
34660 |
diethyl 2-(2-ethoxyethyl)malonate
|
|
C11H20O5 |
详情 |
详情
|
(IV) |
15248 |
1-chloro-2-nitrobenzene
|
88-73-3 |
C6H4ClNO2 |
详情 | 详情
|
(V) |
19483 |
2,2,2-trifluoro-1-ethanol
|
75-89-8 |
C2H3F3O |
详情 | 详情
|
(VI) |
29562 |
2-nitrophenyl 2,2,2-trifluoroethyl ether; 1-nitro-2-(2,2,2-trifluoroethoxy)benzene
|
|
C8H6F3NO3 |
详情 |
详情
|
(VII) |
29563 |
2-(2,2,2-trifluoroethoxy)aniline; 2-(2,2,2-trifluoroethoxy)phenylamine
|
|
C8H8F3NO |
详情 |
详情
|
(VIII) |
34661 |
6-(2,2,2-trifluoroethoxy)-3,5-dihydrofuro[3,2-c]quinolin-4(2H)-one
|
|
C13H10F3NO3 |
详情 |
详情
|
(IX) |
15511 |
o-toluidine; 2-methylphenylamine;2-Methylaniline;2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine |
95-53-4 |
C7H9N |
详情 | 详情
|
(X) |
34662 |
1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H17F3N2O2 |
详情 |
详情
|
(XI) |
34663 |
1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1,5-dihydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H15F3N2O2 |
详情 |
详情
|
(XII) |
34664 |
4-chloro-1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1H-pyrrolo[3,2-c]quinoline; 4-chloro-1-(2-methylphenyl)-1H-pyrrolo[3,2-c]quinolin-6-yl 2,2,2-trifluoroethyl ether
|
|
C20H14ClF3N2O |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(I) Ethanolamine (I) was protected as the N-benzyloxycarbonyl derivative (II) and subsequently converted to tosylate (III). Alkylation of N,N,N'-trimethylethylenediamine (IV) with tosylate (III) produced triamine (V). The benzyloxycarbonyl protecting group was then removed by transfer hydrogenolysis with ammonium formate and Pd/C to yield triamine (VI).
【1】
Ritchie, T.J.; Hallett, A.; Dziadulewicz, E.K.; et al.; 1-(2-Nitrophenyl)thiosemicarbazides: A novel class of potent, orally active non-peptide antagonist for the bradykinin B2 receptor. J Med Chem 2000, 43, 5, 769.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
32497 |
benzyl 2-hydroxyethylcarbamate
|
77987-49-6 |
C10H13NO3 |
详情 | 详情
|
(III) |
42170 |
2-[[(benzyloxy)carbonyl]amino]ethyl 4-methylbenzenesulfonate
|
|
C17H19NO5S |
详情 |
详情
|
(IV) |
15778 |
N-[2-(dimethylamino)ethyl]-N-methylamine; N,N,N'-trimethyl-1,2-ethanediamine; N(1),N(1),N(2)-trimethyl-1,2-ethanediamine
|
142-25-6 |
C5H14N2 |
详情 | 详情
|
(V) |
42316 |
benzyl 2-[[2-(dimethylamino)ethyl](methyl)amino]ethylcarbamate
|
|
C15H25N3O2 |
详情 |
详情
|
(VI) |
42317 |
N-(2-aminoethyl)-N-[2-(dimethylamino)ethyl]-N-methylamine; N(1)-(2-aminoethyl)-N(1),N(2),N(2)-trimethyl-1,2-ethanediamine
|
|
C7H19N3 |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
Reaction of 2-chloronitrobenzene (I) with the sodium alkoxide of 2,2,2-trifluoroethanol (II) in cold THF afforded trifluoroethyl ether (III). The nitro group of (III) was then reduced by means of iron and AcOH to produce 2-(trifluoroethoxy)aniline (IV). Condensation of (IV) with diethyl (2-ethoxyethyl)malonate (V) in boiling diphenyl ether led to the furoquinolinone system (VI), and subsequent reaction of (VI) with 2-methyl-4-methoxyaniline (VII) in refluxing diethylene glycol generated the pyrroloquinolinone (VIII). Chlorination of (VIII) with POCl3 gave chloropyrroloquinoline (IX). Finally, displacement of the chlorine of (IX) by ethanolamine at 180 C yielded the title compound.
【1】
Kim, H.-J.; Kim, S.-S.; Yoo, Y.-K.; Kang, S.-K.; Cheon, H.-G.; Choi, J.-K.; Yum, E.-K. (Korea Research Institute of Chemical Technology); Pyrrolo[3,2-c]quinoline derivs. containing haloalkoxy group and pharmaceutically acceptable salts thereof. CA 2268166; EP 0966466; JP 2000504352; US 6011044; WO 9909029 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
15248 |
1-chloro-2-nitrobenzene
|
88-73-3 |
C6H4ClNO2 |
详情 | 详情
|
(II) |
19483 |
2,2,2-trifluoro-1-ethanol
|
75-89-8 |
C2H3F3O |
详情 | 详情
|
(III) |
29562 |
2-nitrophenyl 2,2,2-trifluoroethyl ether; 1-nitro-2-(2,2,2-trifluoroethoxy)benzene
|
|
C8H6F3NO3 |
详情 |
详情
|
(IV) |
29563 |
2-(2,2,2-trifluoroethoxy)aniline; 2-(2,2,2-trifluoroethoxy)phenylamine
|
|
C8H8F3NO |
详情 |
详情
|
(V) |
34660 |
diethyl 2-(2-ethoxyethyl)malonate
|
|
C11H20O5 |
详情 |
详情
|
(VI) |
34661 |
6-(2,2,2-trifluoroethoxy)-3,5-dihydrofuro[3,2-c]quinolin-4(2H)-one
|
|
C13H10F3NO3 |
详情 |
详情
|
(VII) |
40006 |
4-methoxy-2-methylphenylamine; 4-methoxy-2-methylaniline
|
102-50-1 |
C8H11NO |
详情 | 详情
|
(VIII) |
40007 |
1-(4-methoxy-2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C21H19F3N2O3 |
详情 |
详情
|
(IX) |
40008 |
4-chloro-1-(4-methoxy-2-methylphenyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-6-yl 2,2,2-trifluoroethyl ether; 4-chloro-1-(4-methoxy-2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline
|
|
C21H18ClF3N2O2 |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(XXXIX) In a further procedure, epoxide (XXXII) was condensed with ethanolamine (XXXIX) to afford amino diol (XL). Coupling of (XL) with carbamate (IX) produced the N-(hydroxyethyl)urea (XLI). Chlorination of the primary hydroxyl group of (XLI) with POCl3, followed by cyclization in the presence of Et3N, gave rise to the title imidazolidinone. Alternatively, amino diol (XL) was coupled with 4-nitrophenyl isocyanate (XXXV) to give urea (XLII). Chlorination of (XLII), followed by cyclization in the presence of Et3N, produced imidazolidinone (XLIII). The tetrazolyl group of the target compound was then introduced by catalytic hydrogenation of the nitro group of (XLIII), followed by treatment with NaN3 and triethyl orthoformate.
【3】
Kitazaki, T.; Matsushita, Y.; Hosono, H.; Itoh, K.; Mitsudera, H. (Takeda Chemical Industries, Ltd.); Triazole derivs. and their production. EP 0884311 .
|
【1】
Ichikawa, T.; et al.; Optically active antifungal azoles. XI. An alternative synthetic route for 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone (TAK-456) and its analog. Chem Pharm Bull 2000, 48, 12, 1947. |
【2】
Ichikawa, T.; Matsushita, Y.; Yamada, M.; Tasaka, A.; Yamaguchi, M.; Itoh, K.; Okonogi, K.; Kitazaki, T.; TAK-456 and the water-soluble prodrug TAK-457, new antifungal triazoles: Synthesis and in vitro antifungal activity. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2000, Abst F-1085. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
45560 |
phenyl 4-(1H-1,2,3,4-tetraazol-1-yl)phenylcarbamate
|
|
C14H11N5O2 |
详情 |
详情
|
(XXXII) |
13114 |
1-[[(2S,3S)-2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole
|
|
C12H11F2N3O |
详情 |
详情
|
(XXXIV) |
14909 |
1-isocyanato-4-nitrobenzene; 4-Nitrophenyl isocyanate
|
100-28-7 |
C7H4N2O3 |
详情 | 详情
|
(XXXIX) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XL) |
45578 |
(2R,3R)-2-(2,4-difluorophenyl)-3-[(2-hydroxyethyl)amino]-1-(1H-1,2,4-triazol-1-yl)-2-butanol
|
|
C14H18F2N4O2 |
详情 |
详情
|
(XLI) |
45579 |
N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-N-(2-hydroxyethyl)-N'-[4-(1H-1,2,3,4-tetraazol-1-yl)phenyl]urea
|
|
C22H23F2N9O3 |
详情 |
详情
|
(XLII) |
45580 |
N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-N-(2-hydroxyethyl)-N'-(4-nitrophenyl)urea
|
|
C21H22F2N6O5 |
详情 |
详情
|
(XLIII) |
45581 |
1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-(4-nitrophenyl)-2-imidazolidinone
|
|
C21H20F2N6O4 |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
(VII) Treatment of benzoylacetate derivative (I) with triethyl orthoformate and Ac2O yields derivative (II), which is then subjected to cyclization with N-tert-buxoxycarbonyl-2,4-difluoro-m-phenylenediamine (III) in EtOH, followed by treatment with K2CO3 in DMF, to afford dihydroquinoline ethyl carboxylate derivative (IV). Simultaneous hydrolysis and Boc removal of (IV) with HCl gives carboxylic acid (V), which is then treated with an aqueous solution of methylamine in the presence of pyridine to provide derivative (VI). Finally, the ethanolamine salt of the compound is formed by treatment of (VI) with ethanolamine and pyridine.
【1】
Sakae, N.; Yazaki, A.; Kuramoto, Y.; Yoshida, J.; Niino, Y.; Oshita, Y.; Hirao, Y.; Hayashi, N.; Amano, H. (Wakunaga Pharmaceutical Co., Ltd.); Novel pyridonecarboxylic acid derivs. or salts thereof and drugs containing the same as the active ingredient. EP 0945435; WO 9823592 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45986 |
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methylphenyl)propanoate
|
|
C12H11F3O3 |
详情 |
详情
|
(II) |
45987 |
ethyl (Z)-3-ethoxy-2-(2,4,5-trifluoro-3-methylbenzoyl)-2-propenoate
|
|
C15H15F3O4 |
详情 |
详情
|
(III) |
38179 |
tert-butyl 5-amino-2,4-difluorophenylcarbamate
|
|
C11H14F2N2O2 |
详情 |
详情
|
(IV) |
45988 |
ethyl 1-[5-[(tert-butoxycarbonyl)amino]-2,4-difluorophenyl]-6,7-difluoro-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C24H22F4N2O5 |
详情 |
详情
|
(V) |
45989 |
1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C17H10F4N2O3 |
详情 |
详情
|
(VI) |
45990 |
1-(5-amino-2,4-difluorophenyl)-6-fluoro-8-methyl-7-(methylamino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C18H14F3N3O3 |
详情 |
详情
|
(VII) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线35
该中间体在本合成路线中的序号:
(VIII) Condensation of 4-fluorobenzenesulfonyl chloride (I) with anthranilic acid derivative (II) by means of pyridine yields sulfonamide derivative (III), which is then N-alkylated by reaction with benzyl bromide (IV) by means of NaH in DMF to furnish compound (V). Saponification of the methyl ester group of (V) by treatment with NaOH in refluxing MeOH affords carboxylic acid (VI) (1), which is then converted into compound (X) by condensation with hydroxy derivative (IX) by means of NaH in DMF. (In turn, compound (IX) can be obtained by coupling of 2-benzofurancarboxylic acid (VII) with ethanolamine (VIII) by means of HOBt/EDC and NMM in DMF. Finally, the target product is obtained by derivatization of the carboxylic acid moiety of (X) with hydroxylamine hydrochloride by means of HOBt/EDC and Et3N in DMF.
【2】
Gu, Y.; Nelson, F.C.; Zask, A.; Du, M.T.; Levin, J.I.; Venkatesan, M. (American Cyanamid Co.); Preparation and use of orthosulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors. US 5929097 .
|
【1】
Levin, J.I.; Nilakantan, R.; Mobilio, D.; Chen, J.M.; Nelson, F.C.; Powers, R.; Moy, F.J.; Zask, A.; Structure-based design of a novel, potent, and selective inhibitor for MMP-13 utilizing NMR spectroscopy and computer-aided molecular design. J Am Chem Soc 2000, 122, 40, 9648. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12292 |
4-Fluorobenzenesulfonyl chloride
|
349-88-2 |
C6H4ClFO2S |
详情 | 详情
|
(II) |
47141 |
methyl 2-amino-3,5-dimethylbenzoate
|
|
C10H13NO2 |
详情 |
详情
|
(III) |
47142 |
methyl 2-[[(4-fluorophenyl)sulfonyl]amino]-3,5-dimethylbenzoate
|
|
C16H16FNO4S |
详情 |
详情
|
(IV) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(V) |
47143 |
methyl 2-[benzyl[(4-fluorophenyl)sulfonyl]amino]-3,5-dimethylbenzoate
|
|
C23H22FNO4S |
详情 |
详情
|
(VI) |
47144 |
2-[benzyl[(4-fluorophenyl)sulfonyl]amino]-3,5-dimethylbenzoic acid
|
|
C22H20FNO4S |
详情 |
详情
|
(VII) |
38339 |
Benzofuran-2-carboxylic acid; 1-benzofuran-2-carboxylic acid
|
496-41-3 |
C9H6O3 |
详情 | 详情
|
(VIII) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(IX) |
47145 |
N-(2-hydroxyethyl)-1-benzofuran-2-carboxamide
|
|
C11H11NO3 |
详情 |
详情
|
(X) |
47146 |
2-[[(4-[2-[(1-benzofuran-2-ylcarbonyl)amino]ethoxy]phenyl)sulfonyl](benzyl)amino]-3,5-dimethylbenzoic acid
|
|
C33H30N2O7S |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(IV) 3-Chloroaniline (I) was acylated with chloroacetyl chloride (II) in isopropyl acetate. The resulting chloroacetanilide (III) was condensed with ethanolamine (IV) to yield the (hydroxyethyl)glycinamide (V). Cyclization of (V) to produce the piperazinone (VI) was then effected by treatment with di-tert-butyl azodicarboxylate and tributylphosphine.
【1】
Williams, T.M. (Merck & Co., Inc.); Biaryl inhibitors of prenyl-protein transferase. WO 0075135 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25239 |
3-chloroaniline; 3-chlorophenylamine
|
108-42-9 |
C6H6ClN |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(III) |
47290 |
2-chloro-N-(3-chlorophenyl)acetamide
|
|
C8H7Cl2NO |
详情 |
详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(V) |
47291 |
N-(3-chlorophenyl)-2-[(2-hydroxyethyl)amino]acetamide
|
|
C10H13ClN2O2 |
详情 |
详情
|
(VI) |
47289 |
1-(3-chlorophenyl)-2-piperazinone
|
|
C10H11ClN2O |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(IV) By reaction of 2-aminobenzophenones (I) with bromoacetyl halide (II) or tosyloxyacetyl halide (VI) to give, respectively, 2-(bromoacetylamino)benzophenones (III) or 2-(tosyloxyacetylamino)benzophenones (VII), which are treated with ethanolamine (IV) to give the compounds (V), which with acetic acid in ethanol give the desired compounds. These compounds can also be obtained from (III) and (VI) without isolation of (V)
【1】
Miyadera, T.; et al.; J Heterocycl Chem 1973, 10, 6, 85-88.
|
【2】
Shishoo, C.J.; et al.; Process for the manufacture of pharmacologically active new heterocyclic compounds and salts thereof. IN 151496 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
60640 |
(2-amino-5-bromophenyl)(2-fluorophenyl)methanone
|
|
C13H9BrFNO |
详情 |
详情
|
(II) |
27903 |
2-Bromoacetyl chloride
|
22118-09-8 |
C2H2BrClO |
详情 | 详情
|
(III) |
60641 |
2-bromo-N-[4-bromo-2-(2-fluorobenzoyl)phenyl]acetamide
|
|
C15H10Br2FNO2 |
详情 |
详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(V) |
60642 |
N-[4-bromo-2-(2-fluorobenzoyl)phenyl]-2-[(2-hydroxyethyl)amino]acetamide
|
|
C17H16BrFN2O3 |
详情 |
详情
|
(VI) |
60643 |
2-chloro-2-oxoethyl 4-methylbenzenesulfonate
|
|
C9H9ClO4S |
详情 |
详情
|
(VII) |
60644 |
2-[4-bromo-2-(2-fluorobenzoyl)anilino]-2-oxoethyl 4-methylbenzenesulfonate
|
|
C22H17BrFNO5S |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(III) Formation in anhydrous medium of the acyl halide (II) of dl-2-(4'-isobutylphenyl)propionic acid (I) with phosphorous or sulfur halides or oxyhalides, and the subsequent reaction in anhydrous medium with beta-hydroxyethylamine (III) to give N-(beta-hydroxyethyl)-dl-2-(4’-isobutylphenyl)propionamide.
【1】
McKenney, D.; et al.; Aminoprofen. Drugs Fut 1981, 6, 10, 599.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52312 |
2-(4-Isobutylphenyl)propionic acid; Ibuprofen
|
15687-27-1 |
C13H18O2 |
详情 | 详情
|
(II) |
22117 |
2-(4-isobutylphenyl)propanoyl chloride
|
|
C13H17ClO |
详情 |
详情
|
(III) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(IX) Diethyl malonate (I) was alkylated with 2-bromoethyl ethyl ether (II) to provide diethyl (2-ethoxyethyl)malonate (III). Subsequent condensation of malonate (III) with 2-(trifluoromethoxy)aniline (IV) in boiling diphenyl ether generated the furoquinoline derivative (V). This was then condensed with 2-methyl-4-methoxyaniline (VI) in refluxing diethylene glycol to furnish adduct (VII). Chlorination of pyrroloquinolone (VII) with phosphoryl chloride gave rise to the chloro pyrroloquinoline (VIII). The chloro group of (VIII) was finally displaced with ethanolamine (IX) at 190 C, yielding the title compound.
【1】
Kim, H.-J.; Kim, S.-S.; Yoo, Y.-K.; Kang, S.-K.; Cheon, H.-G.; Choi, J.-K.; Yum, E.-K. (Korea Research Institute of Chemical Technology); Pyrrolo[3,2-c]quinoline derivs. containing haloalkoxy group and pharmaceutically acceptable salts thereof. CA 2268166; EP 0966466; JP 2000504352; US 6011044; WO 9909029 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
34659 |
2-bromoethyl ethyl ether; 1-bromo-2-ethoxyethane
|
592-55-2 |
C4H9BrO |
详情 | 详情
|
(III) |
34660 |
diethyl 2-(2-ethoxyethyl)malonate
|
|
C11H20O5 |
详情 |
详情
|
(IV) |
51625 |
2-trifluoromethoxyaniline; alpha,alpha,alpha-trifluoro-o-anisidine; o-trifluoromethoxyaniline
|
1535-75-7 |
C7H6F3NO |
详情 | 详情
|
(V) |
51626 |
6-(trifluoromethoxy)-3,5-dihydrofuro[3,2-c]quinolin-4(2H)-one
|
|
C12H8F3NO3 |
详情 |
详情
|
(VI) |
40006 |
4-methoxy-2-methylphenylamine; 4-methoxy-2-methylaniline
|
102-50-1 |
C8H11NO |
详情 | 详情
|
(VII) |
51627 |
1-(4-methoxy-2-methylphenyl)-6-(trifluoromethoxy)-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H17F3N2O3 |
详情 |
详情
|
(VIII) |
51628 |
4-chloro-1-(4-methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline; 4-chloro-1-(4-methoxy-2-methylphenyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-6-yl trifluoromethyl ether
|
|
C20H16ClF3N2O2 |
详情 |
详情
|
(IX) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(II) It can be prepared in several different ways:
1) By condensation of (I) with ethanolamine (II) by means of triethylamine in dioxane that gives 2-(2-hydroxyethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (III), which is then esterified with methanesulfonyl chloride and triethylamine in dioxane. (1,2)
2) By condensation of 2-chloro-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (I) with 2-(methylsulfonyloxy)ethylamine by means of triethylamine (IV) in CH2Cl2. (1,2)
3) By condensation of (I) with 2-chloroethylamine (V) by means of triethylamine in CH2Cl2 that gives 2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (VI), which is then transformed into the ester by means of silver methanesulfonate in refluxing acetonitrile. (1,2)
4) By cyclization at N-(3-hydroxypropyl)-2-chloroethylamine (VII) with N-(2-methylsulfonyl-oxyethyl)dichlorophosphoramide (VIII) by means of triethylamine in CH2Cl2. (1,2)
5) By mesylation of 2-(ethyleneimino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaza-phosphorine-2-oxide (IX) with methanesulfonic acid in ethyl ether. (1,2)
【1】
(Asta-Werke A.G.); FR 2125595 .
|
【2】
Arnold, H.; et al. (Asta-Werke A.G.); DE 2107936 .
|
【3】
Castaner, J.; Hillier, K.; Sufosfamide. Drugs Fut 1977, 2, 5, 339.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40966 |
2-chloro-3-(2-chloroethyl)-1,3,2lambda(5)-oxazaphosphinan-2-one
|
|
C5H10Cl2NO2P |
详情 |
详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
60926 |
3-(2-chloroethyl)-2-[(2-hydroxyethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C7H16ClN2O3P |
详情 |
详情
|
(IV) |
60931 |
2-aminoethyl methanesulfonate
|
|
C3H9NO3S |
详情 |
详情
|
(V) |
33455 |
2-chloro-1-ethanamine; 2-chloroethylamine
|
|
C2H6ClN |
详情 |
详情
|
(VI) |
60927 |
3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C7H15Cl2N2O2P |
详情 |
详情
|
(VII) |
60930 |
3-[(2-chloroethyl)amino]-1-propanol
|
|
C5H12ClNO |
详情 |
详情
|
(VIII) |
60929 |
2-[(dichlorophosphoryl)amino]ethyl methanesulfonate
|
|
C3H8Cl2NO4PS |
详情 |
详情
|
(IX) |
60928 |
2-(1-aziridinyl)-3-(2-chloroethyl)-1,3,2lambda~5~-oxazaphosphinan-2-one
|
|
C7H14ClN2O2P |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(III) The reaction of 2-benzoylbenzoic acid (I) with SOCl2 in CHCl3, benzene or DMF gives the corresponding acyl chloride (II), which is condensed with ethanolamine (III) by means of TEA in CHCl3 to yield the amide (IV). The reduction of (IV) with LiAlH4 in THF affords the diol (V), which is cyclized by means of Ts-OH in refluxing benzene to provide 1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine (VI). Finally, this compound is methylated by means of dimethyl sulfate in refluxing benzene, or by means of formaldehyde in hot dioxane/water.
Alternatively, the cyclization of N-[2-[1-[2-(chloromethyl)phenyl]-1-phenylmethoxy]ethyl]-N-methylamine (VII) by means of pyridine in refluxing acetonitrile gives also the target benzoxazocine.
【1】
Lazaro Porta, A.; Process for the preparation of diphenylcarbinol derivs.. ES 8100663 .
|
【2】
Calatayud, J.; Luna, M.; Process for the preparation of 5-phenyl-1-methyl-1-aza-4-oxa-6,7-benzocyclooctane hydrochloride. ES 8605495 .
|
【3】
Colls Alsius, J.; Process for the preparation of of a heterocyclic tertiary amine. ES 8607261 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59365 |
2-benzophenone carboxylic acid; 2-Benzoylbenzoic acid; 2-Carboxybenzophenone; Benzophenone-2-carboxylic acid; O-benzoylbenzoic acid
|
85-52-9 |
C14H10O3 |
详情 | 详情
|
(II) |
59366 |
2-benzoylbenzoyl chloride
|
|
C14H9ClO2 |
详情 |
详情
|
(III) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(IV) |
59367 |
2-benzoyl-N-(2-hydroxyethyl)benzamide
|
|
C16H15NO3 |
详情 |
详情
|
(V) |
59368 |
2-({2-[hydroxy(phenyl)methyl]benzyl}amino)-1-ethanol
|
|
C16H19NO2 |
详情 |
详情
|
(VI) |
59369 |
1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine
|
|
C16H17NO |
详情 |
详情
|
(VII) |
59370 |
2-[[2-(chloromethyl)phenyl](phenyl)methoxy]-N-methyl-1-ethanamine; N-{2-[[2-(chloromethyl)phenyl](phenyl)methoxy]ethyl}-N-methylamine
|
|
C17H20ClNO |
详情 |
详情
|
合成路线42
该中间体在本合成路线中的序号:
(I) The precursor triamine (VI) is prepared as follows. Ethanolamine (I) is protected as the N-Cbz derivative (II) upon treatment with N-(benzyloxycarbonyloxy)succinimide. Subsequent tosylation of (II) to yield (III), followed by displacement of the tosylate of (III) with trimethyl propanediamine (IV) furnishes the protected triamine (V). Then, Cbz group hydrogenolysis in (V) in the presence of Pd/C gives rise to triamine (VI).
【1】
Dziadulewicz, E.K.; et al.; Nonpeptide bradykinin B2 receptor antagonists: Conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists. J Med Chem 2002, 45, 11, 2160.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
30663 |
N-benzyloxycarbonyloxysuccinimide; 1-[[(Benzyloxy)carbonyl]oxy]-2,5-pyrrolidinedione
|
13139-17-8 |
C12H11NO5 |
详情 | 详情
|
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
32497 |
benzyl 2-hydroxyethylcarbamate
|
77987-49-6 |
C10H13NO3 |
详情 | 详情
|
(III) |
42170 |
2-[[(benzyloxy)carbonyl]amino]ethyl 4-methylbenzenesulfonate
|
|
C17H19NO5S |
详情 |
详情
|
(IV) |
28165 |
N-[3-(dimethylamino)propyl]-N-methylamine
|
4543-96-8 |
C6H16N2 |
详情 | 详情
|
(V) |
61665 |
benzyl 2-[[3-(dimethylamino)propyl](methyl)amino]ethylcarbamate
|
|
C16H27N3O2 |
详情 |
详情
|
(VI) |
61664 |
N~1~-(2-aminoethyl)-N~1~,N~3~,N~3~-trimethyl-1,3-propanediamine
|
|
C8H21N3 |
详情 |
详情
|
合成路线43
该中间体在本合成路线中的序号:
(I) Esterification of ethanolamine hydrochloride (I) by means of acetyl chloride in HOAc yields 2-aminoethyl acetate (II). The carboxyl groups of folic acid (III) are protected by coupling with amino ester (II) in the presence of EDC, to produce diamide (IV). Subsequent condensation of (IV)with dimethylformamide diethylacetal (DMF-DEA) gives formamidine (V). The 4-carbonyl group of (V) is then protected as the phenethyl ether (VII) by treatment with 4-nitrophenethyl alcohol (VI) under Mitsunobu coupling conditions.
【1】
Frank, A.; Karn, H.; Spanig, H. (Abbott GmbH & Co. KG); Production of 1-hydroxyalkyl-5-nitroimidazoles. DE 2359625; FR 2253019; GB 1481349 .
|
【2】
Frank, A.; Dockner, T.; Karn, H. (Abbott GmbH & Co. KG); Process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. EP 0150407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
59032 |
2-aminoethyl acetate
|
|
C4H9NO2 |
详情 |
详情
|
(III) |
59033 |
N-(4-{[(2-amino-4-oxo-3,4-dihydro-6-pteridinyl)methyl]amino}benzoyl)glutamic acid
|
|
C19H19N7O6 |
详情 |
详情
|
(IV) |
59034 |
2-({5-{[2-(acetyloxy)ethyl]amino}-2-[(4-{[(2-amino-4-oxo-3,4-dihydro-6-pteridinyl)methyl]amino}benzoyl)amino]-5-oxopentanoyl}amino)ethyl acetate
|
|
C27H33N9O8 |
详情 |
详情
|
(V) |
59035 |
2-({5-{[2-(acetyloxy)ethyl]amino}-2-[(4-{[(2-{[(E)-(dimethylamino)methylidene]amino}-4-oxo-3,4-dihydro-6-pteridinyl)methyl]amino}benzoyl)amino]-5-oxopentanoyl}amino)ethyl acetate
|
|
C30H38N10O8 |
详情 |
详情
|
(VI) |
32472 |
2-(4-nitrophenyl)-1-ethanol
|
100-27-6 |
C8H9NO3 |
详情 | 详情
|
(VII) |
59036 |
2-{[5-{[2-(acetyloxy)ethyl]amino}-2-({4-[({2-{[(E)-(dimethylamino)methylidene]amino}-4-[(4-nitrophenethyl)oxy]-6-pteridinyl}methyl)amino]benzoyl}amino)-5-oxopentanoyl]amino}ethyl acetate
|
|
C38H45N11O10 |
详情 |
详情
|
合成路线44
该中间体在本合成路线中的序号:
(IV) Regioselective substitution of the 2-chloro group of 2,4-dichloroquinoline (I) with 1,2,3,4-tetrahydroisoquinoline (II) in refluxing toluene provides the 2-(tetrahydroisoquinolinyl)quinoline (III). Then, displacement of the remaining 4-chloro group by heating with ethanolamine (IV) furnishes the title compound
【1】
Pinard, E.; Alanine, A.; Bourson, A.; Buttelman, B.; Heitz, M.-P.; Mutel, V.; Gill, R.; Trube, G.; Wyler, R.; 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med. Chem. Lett 2002, 12, 18, 2615.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61332 |
2,4-Dichloroquinoline
|
|
C9H5Cl2N |
详情 |
详情
|
(II) |
14124 |
1,2,3,4-Tetrahydroisoquinoline
|
91-21-4 |
C9H11N |
详情 | 详情
|
(III) |
61333 |
4-chloro-2-[3,4-dihydro-2(1H)-isoquinolinyl]quinoline
|
|
C18H15ClN2 |
详情 |
详情
|
(IV) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线45
该中间体在本合成路线中的序号:
(XXVII) The pyrrolo-oxazine fragments, the free base (II) or the Boc-protected (V) can be synthesized as follows. Butene-1,4-diol (XXIV) is subjected to either of the two following alternative procedures: 1) treatment with mesyl chloride in the presence of Et3N in CH2Cl2 and subsequent reaction with tosylamine, NaOH and tetrabutylammonium hydrogensulfate (TBAHS) in toluene/water at 40 °C (1, 2); or 2) chlorination with thionyl chloride followed by treatment with tosylamide by means of NaH in DMF (3) to afford 1-tosyl-2,5-dihydro-1H-pyrrole (XXV). Compound (XXV) is then epoxidated with meta-chloroperbenzoic acid (mCPBA) in refluxing dichloromethane to yield cis-N-tosyl-6-oxa-3-azabicyclo[3.1.0]hexane (XXVI) (1-3). Desymmetrization of intermediate (XXVI) is carried out by condensation with ethanolamine (XXVII) in refluxing dichloromethane to yield the racemic N-alkylated pyrrolidine derivative rac-(XXVIII), which by reaction with tosyl chloride in pyridine/THF at –10 °C affords the tosylate rac-(XXIX). Cyclization of the racemic (XXIX) by means of NaOH in THF/methanol at 0-3 °C gives the racemic pyrrolo-oxazine rac-(XXX), from which the desired enantiomer (4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine (XXX) is separated by chiral chromatography. Finally, compound (XXX) is detosylated by means of HBr/AcOH and anisole at 60 °C and the resulting dihydrobromide salt (XXXI) is treated with potassium hydroxide in isopropanol to afford the free base intermediate (II) (1). Scheme 3.
In an improved method for intermediate (II), compound (XXVI) is desymmetrized by coupling with (R)-phenylethylamine (XXXII) in water (2, 3), resulting in a mixture of diastereomers that is resolved by crystallization (2) or chromatography (3). The desired isomer (XXXIII) is N-acylated with chloroacetyl chloride (XXXIV) by means of triethylamine (2) or DIEA in THF (3) to afford the N-chloroacetyl amine (XXXV), which then cyclizes in the presence of sodium hydroxide (2) or potassium tert-butoxide in dichloromethane (3). The resulting bicyclic lactam (XXXVI) is reduced with LiAlH4 in THF (3) or NaBH4 in the presence of BF3.THF complex (2) to give the pyrrolooxazine derivative (XXXVII) (2, 3), which is detosylated by treatment with HCl and subsequently with NaOH, yielding the free amine (XXXVIII). Finally, compound (XXXVIII) is subjected to hydrogenolysis over Pd/C in methanol to afford the target (4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine (II) (2). Scheme 3.
The Boc-protected compound (V) is obtained by subjecting N-alkylated derivative (XXXVII) to hydrogenolysis over Pd/C in methanol followed by treatment with tert-butoxycarbonyl anhydride in dichloromethane. The resulting fully protected intermediate (XXXIX) is finally detosylated with sodium naphthalenide (3). Scheme 3.
【1】
Matzke, M., Petersen, U., Schenke, T. et al. (Bayer Healthcare AG). Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases. CA 2274894, DE 19652239, EP 0946176, JP 200351781, JP 2000514825, US 6133260, US 6432948, WO 1998026779. |
【2】
Wohlert, S.E., Jaetsch, T., Gallenkamp, B. et al. New fluoroquinolone finafloxacin HCI (FIN): Route of synthesis, physicochemical characteristics and activity under neutral and acid conditions. 48th Annu Intersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst F1-2036. |
【3】
Hong, J., Zhang, Z., Lei, H. et al. A novel approach to finafloxacin hydrochloride (BAY35-3377). Tetrahedron Lett 2009, 50(21): 2525-8. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
65947 |
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine |
|
C6H12N2O |
详情 | 详情
|
(V) |
65950 |
|
|
C11H20N2O3 |
详情 | 详情
|
(XXIV) |
36965 |
(Z)-2-butene-1,4-diol
|
6117-80-2 |
C4H8O2 |
详情 | 详情
|
(XXV) |
65968 |
1-(Toluene-4-sulfonyl)-2,5-dihydro-1H-pyrrole; 1-(p-Tolylsulfonyl)-3-pyrroline; 1-(4-Methylphenylsulfonyl)-2,5-dihydropyrrole; 2,5-Dihydro-1-[(4-methylphenyl)sulfonyl]-1H-pyrrole |
16851-72-2 |
C11H13NO2S |
详情 | 详情
|
(XXVI) |
65969 |
3-Tosyl-6-oxa-3-azabicyclo[3.1.0]hexane |
159555-66-5 |
C11H13NO3S |
详情 | 详情
|
(XXVII) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XXVIII) |
65970 |
2,5-Dihydro-3-hydroxy-4-[(2-hydroxyethyl)amino]-1-[(4-methylphenyl)sulfonyl]-1H-pyrrole |
|
C13H20NO4S |
详情 | 详情
|
(XXIX) |
65971 |
|
|
C20H26NO6S2 |
详情 | 详情
|
(XXX) |
65972 |
|
|
C20H24N2O5S2 |
详情 | 详情
|
(XXXI) |
65973 |
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine dihydrobromide |
|
C6H12N2O.2HBr |
详情 | 详情
|
(XXXII) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
(XXXIII) |
65974 |
|
|
C19H24N2O3S |
详情 | 详情
|
(XXXIV) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(XXXV) |
65975 |
|
|
C21H25ClN2O4S |
详情 | 详情
|
(XXXVI) |
65976 |
|
|
C21H24N2O4S |
详情 | 详情
|
(XXXVII) |
65977 |
|
|
C21H26N2O3S |
详情 | 详情
|
(XXXVIII) |
65978 |
|
|
C14H20N2O |
详情 | 详情
|
(XXXIX) |
65979 |
|
|
C18H26N2O5S |
详情 | 详情
|
合成路线46
该中间体在本合成路线中的序号:
(XIX) Enantioselective synthesis of suvorexant is based on enzymatic transamination and described as follows. Cyclization of 2-amino-4-chlorophenol (XVI) with trimethyl orthoformate HC(OMe)3 in the presence of p-TsOH in THF provides 5-chlorobenzoxazole (XVII), which subsequently reacts with LiHMDS in THF followed by bromination of the resulting anion with NBS to afford 2-bromo-5-chlorobenzoxazole (XVIII). Condensation of crude bromo derivative (XVIII) with ethanolamine (XIX) in acetonitrile gives 2-(5-chloro-2-benzoxazolylamino)ethanol (XX), which is subjected to aza-Michael addition with methyl vinyl ketone (II) in the presence of NaOH in DMF to yield the β-amino ketone (XXI). Activation of crude alcohol (XXI) with MsCl in the presence of Et3N in i-PrOAc provides keto mesylate (XXII), which by transamination and cyclization with i-PrNH2 in the presence of CDX-017 enzyme and pyridoxal phosphate in DMSO, and subsequent acidification with HCl, provides the (R)-azepane derivative (XXIII). Finally, Schotten-Baumann acylation of amine (XXIII) with 5-methyl-2-(1,2,3-triazol-2-yl)benzoyl chloride (XXIV) in the presence of K2CO3 in i-PrOAc/H2O affords suvorexant. Chloride (XXIV) was prepared from 5-methyl-2-(1,2,3-triazol-2-yl)benzoic acid (IX) by treatment with (COCl)2 in the presence of DMF in i-PrOAc .
【1】
Mangion, I.K., Sherry, B.D., Yin, J., Fleitz, F.J. Enantioselective synthesis of a dual orexin receptor antagonist. Org Lett 2012, 14(13): 3458-61. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
30324 |
3-buten-2-one; methyl vinyl ketone
|
78-94-4 |
C4H6O |
详情 | 详情
|
(IX) |
67936 |
5-methyl-2-(1,2,3-triazol-2-yl)benzoic acid |
|
C10H9N3O2 |
详情 | 详情
|
(XVI) |
67942 |
2-amino-4-chlorophenol |
95-85-2 |
C6H6ClNO |
详情 | 详情
|
(XVII) |
67943 |
5-chlorobenzo[d]oxazole |
17200-29-2 |
C7H4ClNO |
详情 | 详情
|
(XVIII) |
67944 |
2-bromo-5-chlorobenzo[d]oxazole |
|
C7H3BrClNO |
详情 | 详情
|
(XIX) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XX) |
67945 |
2-(5-chloro-2-benzoxazolylamino)ethanol |
|
C9H9ClN2O2 |
详情 | 详情
|
(XXI) |
67946 |
4-((5-chlorobenzo[d]oxazol-2-yl)(2-hydroxyethyl)amino)butan-2-one |
|
C13H15ClN2O3 |
详情 | 详情
|
(XXII) |
67947 |
2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethyl methanesulfonate |
|
C14H17ClN2O5S |
详情 | 详情
|
(XXIII) |
67948 |
(R)-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole hydrochloride |
|
C13H16ClN3O.HCl |
详情 | 详情
|
(XXIV) |
67949 |
5-methyl-2-(1,2,3-triazol-2-yl)benzoyl chloride |
|
C10H8ClN3O |
详情 | 详情
|
合成路线47
该中间体在本合成路线中的序号:
(I)
【1】
Moon YH,Kim ND,Lee KI,et al.Method for preparing amlodipine:US,Patent 2,002,132,834,2002. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
24848 |
acetonyl acetone;1,2-Diacetylethane;a,b-Diacetylethane;2,5-Diketohexane;Diacetonyl;Acetonylacetone;2,5-Dioxohexane;2,5-hexanedione |
110-13-4 |
C6H10O2 |
详情 | 详情
|
(III) |
69573 |
2-(2,5-Dimethylpyrrol-1-yl)ethanol;1H-Pyrrole-1-ethanol,2,5-dimethyl-;1-(2-Hydroxyethyl)-2,5-dimethylpyrrole;1-Hydroxyethyl-2,5-dimethylpyrrole |
83662-06-0 |
C8H13NO |
详情 | 详情
|
(IV) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(V) |
69574 |
ethyl 4-(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethoxy)-3-oxobutanoate |
|
C14H21NO4 |
详情 |
详情
|
(VI) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VII) |
69569 |
Methyl 3-aminocrotonate;Methyl 3-amino-2-butenoate;(Z)-methyl 3-aminobut-2-enoate |
14205-39-1 |
C5H9NO2 |
详情 | 详情
|
(VIII) |
69575 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(2,5-dimethyl-1H-pyrrol-1-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
|
C26H31ClN2O5 |
详情 |
详情
|
(IX) |
69570 |
Benzenesulfonic acid;Phenylsulfonic acid;Benzenemonosulfonic acid;Benzensulfonic acid;Benzenesulphonic acid; |
98-11-3 |
C6H6O3S |
详情 | 详情
|